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ABSTRACT 
Background: The advent of antiretroviral therapy (ART) has significantly redefined the course 
of the HIV pandemic making HIV, a chronic illness rather than a death sentence. To maximise 
the efficacy of ART in improving survival rates of HIV/AIDS patients, lowering the incidence of 
opportunistic infections, reducing HIV transmission and minimising the possibilities of 
developing drug resistance, long-term retention in care is critical. In South Africa, poor retention 
in care of 32% has been noted in women who were initiated on ART during pregnancy as 
compared to 13% in non-pregnant women initiated on ART. However, little is known in 
Swaziland about the retention in care in women who were initiated on ART during pregnancy 
and the factors that influence retention in care among this category of women. 
Aim: To determine the factors associated with poor retention in care among women initiated on 
ART during pregnancy at King Sobhuza II Public Health Unit (PHU) in Swaziland. 
Methodology: A quantitative, retrospective cohort review of 316 medical records of women 
who were initiated on ART during pregnancy from January 2012 to December 2013 was 
conducted. A data extraction sheet was used to collect data from the files of patients who were 
initiated on ART during pregnancy. The dataset was imported into IBM SPSS Statistic 20 
Software for analysis. Bi-variate analysis was done to determine risk factors associated with 
retention in ART care at ART initiation and on the last ART refill visit. Kaplan-Meier analysis 
was used to determine retention in care at 6, 12, 24 and 36 months. Cox proportional hazards 
models were then used to determine factors associated with poor retention. 
Results: The overall retention rate of women who were initiated on ART during pregnancy at the 
PHU after a median duration on ART of 25.80 months [interquartile range (IQR): 16.70 – 30.98] 
of follow up was 74.1% (n=316). Most women initiated on ART during pregnancy (52.4%) 
became lost to follow up after giving birth as compared to 47.6% who became lost to follow up 
before giving birth. After 6 months on ART, the lost to follow up rate was 16.5% (n=316); but 
increased to 20.9% (n=316), 23.5% (n=243) and 26.9% (n=52) after 12, 24 and 36 months 
respectively. On the ART initiation visit, the factors associated with retention in care for 
pregnant women included being married, having the partner on ART, disclosing one’s HIV 
status to the partner, not drinking alcohol, being a non-smoker and reporting no financial 
challenges. In addition, on the last ART refill visit, the risk factors for retention in care for 
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women initiated on ART during pregnancy were having the ART regimen changed, having 
regular CD4 cell count done, rise in CD4 cell count, good adherence on ART and use of 
contraceptive other than the condom for family planning after delivery. 
 
Conclusion: The retention in care for women who were initiated on ART during pregnancy was 
found to be lower than in the general adult population. However, the study findings on retention 
in care are similar to what has been found in other settings. The factors influencing poor 
retention also mirror those found in the other parts of sub-Saharan Africa. Whilst decentralisation 
of ART services improves ART coverage it should be coupled with strategies aimed at 
improving patient retention.  
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Operational Definitions 
 
Retention in care: Refers to patients who are known to be alive and active on ART at the end of 
a follow up period. 
 
Attrition: Refers to any discontinuation of ART including death, loss to follow-up, and stopping 
ARV medications while remaining in care. 
 
Lost to follow-up: Refers to patients receiving ART who are more than 3 months late for a 
scheduled ART refill visit and are not transferred out or dead. 
 
Transfer out: Patient transferred by healthcare workers to any other facilities. 
 
Self-referral: Patients who moved to another location but without any official referral or transfer 
by health care workers.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
1 INTRODUCTION 
1.1 Background 
The introduction of antiretroviral therapy (ART) in the 1990s brought new hope to people living 
with HIV/AIDS (Reynolds, 2003). In spite of the major achievements towards combating 
HIV/AIDS, the burden of HIV infection in sub-Saharan Africa remains very high (Colvin et al., 
2014). According to UNAIDS (2014), an estimated 24.7 million of people living with HIV 
(PLHIV) reside in sub-Saharan Africa, representing about 70% of global prevalence and 58% of 
them are women. Although new HIV infections have declined by 33% between 2005 and 2013, 
the new infections remain high at an estimated 1.5 million. With the advent of antiretroviral 
drugs (ARVs), the number of AIDS-related deaths in sub-Saharan Africa dropped by 39% from 
1.5 million to 1.1 million people by 2013. There has been a 43% decline from just above 300,000 
to 210,000 new HIV infections among children in sub-Saharan Africa from 2009 to 2013; with 
mother to child transmission accounting for an estimated 90% of the total HIV infections in 
children (UNAIDS, 2008).  
ART can produce dramatic clinical improvements in people with symptomatic HIV infection 
(Stevens, Kaye & Corrah, 2004). According to UNAIDS (2005), the increased availability of 
antiretroviral drugs (ARVs) for the treatment of HIV in PLHIV including  pregnant women, has 
dramatically improved survival rates, lowered the incidence of opportunistic infections and 
reduced HIV transmission to infants and HIV negative partners. Unfortunately, some sub-
Saharan countries could not realise these treatment outcomes early due to delays in establishing 
ART programmes. Chigwedere, Seage, Gruskin, Lee and Essex (2008) highlight that delayed 
implementation of ART programme in South Africa resulted in a loss of at least 330,000 lives, 
which are equivalent to about 2.2 million person-years. In addition, 35,000 babies acquired HIV 
vertically, resulting in 1.6 million person-years lost by not implementing a timely and feasible 
PMTCT programme using single dose Nevirapine prophylaxis.  
Swaziland is one of the sub-Saharan African countries severely affected by the HIV/AIDS 
epidemic. The country is one of the 30 low and middle-income countries that account for 89% of 
all new HIV infections (UNAIDS, 2014). The incidence and prevalence rates among adults aged 
18-49 years old are 2.4% per year and 31% respectively (Swaziland Ministry of Health, 2012b). 
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In addition, the prevalence rate of HIV in pregnant women is very high; estimated at 41.1% 
(Swaziland Ministry of Health, 2014), which translates to approximately 13,563 HIV exposed 
infants delivered annually. Nevertheless, the Swaziland government has made major strides 
towards achieving high ART coverage in all population with less than 10% of pregnant women 
living with HIV not receiving ARVs in 2013. The implementation of the prevention of mother to 
child transmission of HIV (PMTCT) programme as from 2003 has tremendously reduced mother 
to child transmission of HIV from an estimated 35% in 2007 to 12.6% in 2012 (Swaziland 
Ministry of Health, 2014). In an effort to achieve Millennium Development Goals by 2015 and 
UNAIDS 90-90-90 targets by 2020, Swaziland has redirected efforts towards virtual elimination 
of new paediatric HIV infections. 
Many countries have embarked on the Fast-Track strategy to end the AIDS epidemic by 2030. 
Without scale-up, the AIDS epidemic will continue to outrun the response, increasing the long-
term need for HIV treatment and increasing future costs (UNAIDS, 2014). According to the Fast 
Tract 2020 targets, 90% of all people living with HIV should know their HIV status, 90% of all 
people with diagnosed HIV infection should be linked and sustained on antiretroviral therapy, 
and 90% of all people receiving ART should have viral suppression. For viral suppression to 
occur, McMahon et al. (2013) underscored the need for interventions that foster optimal 
adherence. In circumstances of optimal adherence, ART can delay the progression of the HIV 
infection by inhibiting viral replication. Cohen et al. (2011) supplement that consistent and 
optimal adherence to ART significantly reduces the chances of vertical and horizontal 
transmission of HIV. 
In addition to the provision of ART and maintenance of optimal adherence, retention in care is 
one of the key determinants of HIV treatment success (Thompson et al., 2012). Both adherence 
to ART and retention in care are necessary to optimise the clinical outcomes in PLHIV. 
However, most of the studies conducted in resource-limited settings have focused solely on 
adherence to treatment and have provided limited information on effective and practical 
approaches to improve retention in care (Patel et al., 2010; Hodgson et al., 2014). World Health 
Organisation (2011) defines retention in ART care as continuous engagement with the health 
facility from the time of ART initiation to ensure lifelong ART. There is need for sustained 
retention in care for optimal clinical outcomes to be realised in PLHIV. So far, studies have not 
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shown any benefits of discontinuing therapy. Rather, the Strategies for Management of 
Antiretroviral Therapy (SMART) Study Group (2006) noted that ART interruption has 
deleterious effects leading to faster progression of HIV infection, emergence of HIV drug 
resistance and increased HIV vertical and horizontal transmission. Stevens, Kaye and Corrah 
(2004) also highlighted that stopping ART results in high viral loads, which can further increase 
the risk of transmission within a community, to sexual partners and to the children during 
pregnancy, labour, delivery and the postnatal period. 
Scientific evidence shows that retention in care is a critical element of clinical success at both 
patient and programme level. While good patient outcomes among PLHIV on ART have been 
associated with attending clinical appointments (Nachega et al., 2006), high mortality and 
morbidity for ART clients have a positive association with poor retention in both high-income 
and resource-limited settings (Amuron et al., 2009). According to Jarret and Mwamburi (2009), 
patients who are not retained in care are generally sicker than those who are retained in care and 
experience poorer long-term outcomes. Sustained retention in care, therefore, becomes a 
prerequisite for any programme to achieve optimal clinical HIV treatment outcomes. 
 
1.2 Problem Statement 
Poor retention in care has a potential negative impact on outcomes of both PMTCT and ART 
programmes. Studies have shown that pregnant women have a lower likelihood of being retained 
in care than non-pregnant women (Myer et al., 2012; Dourado et al., 2014). In the neighbouring 
South Africa, studies have shown low retention rates of 68% in women who were initiated on 
ART during pregnancy women as compared to 87% in non-pregnant women initiated on ART 
(Toro et al., 2010). The available ART retention data in the country for the general adult 
population shows the retention rate of 78% at 3 years (Swaziland Ministry of Health, 2014),  
Although considerable coverage data is collected in Swaziland, there is paucity of ART retention 
data throughout the PMTCT interventions including retention in care for women initiated on 
ART during pregnancy. Geng et al. (2010a) highlight that the extent and the factors associated 
with retention vary substantially and encourage studies in different settings to inform 
programmatic decisions. 
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1.3 Aim and Objectives 
 
Aim 
The aim of this study was to determine the factors associated with poor retention in care among 
women initiated on ART during pregnancy at King Sobhuza II PHU in Swaziland. 
 
Objectives 
 
1. To describe the demographic, socioeconomic and clinical profile of pregnant women 
who were initiated on ART at King Sobhuza II PHU in Swaziland. 
2. To describe retention in care among women who were initiated on ART during 
pregnancy before and after delivery. 
3. To determine the retention in care for women initiated on ART during pregnancy at 6, 
12, 24 and 36 months. 
4. To determine clinical, socioeconomic and health system related risk factors of 
retention in care among women initiated on ART during pregnancy at King Sobhuza 
II PHU in Swaziland.  
 
1.4 Outline of thesis 
In Chapter 2, a literature review of different scientific sources on retention in care for different 
population groups including pregnant women and factors associated with retention among 
patients on ART in different settings will be outlined.  
Chapter 3 will delineate the research methodology which includes an overview of the study 
design, description of the study setting, the process of data collection, and a synopsis of the 
ethical considerations used for the study.  
Thereafter, in Chapter 4, the results obtained from the study will be presented with focus on both 
significant and non-significant factors. 
Chapter 5 will focus on the discussion of the study findings. 
In Chapter 6, the conclusion and recommendations from the study will be presented.  
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2 LITERATURE REVIEW 
2.1 Introduction  
Retention in ART care has been a topic of research for more than a decade (World Health 
Organisation, 2011). However, the introduction of the 2013 World Health Organisation (WHO) 
Guidelines which recommended ART for all HIV positive pregnant and lactating women has 
pushed retention in care for women initiated on ART during pregnancy into a high priority 
agenda for PMTCT and ART programmes. Swaziland chose Option B+ which entails ART 
initiation for all HIV positive pregnant and lactating women regardless of CD4 cell count and/ or 
the WHO clinical stage. The ART initiation in all HIV positive pregnant and lactating women 
highlights the need for accurate methods of monitoring retention in care through the continuum 
of antenatal care and into adult ART follow-up systems (Rollins et al., 2014).  
Scientific evidence identifies retention in care as a key element for improved clinical outcomes at 
both patient and programme level. A retrospective cohort by Rich et al., (2012) reinforces 
published evidence by demonstrating that HIV treatment outcomes in resource-limited settings 
can match or exceed those in wealthy countries if long term retention rates are maintained above 
90%. In addition, the study proves that excellent results can be sustained in large programmes. 
Therefore, sustained high long-term retention in care becomes crucial for any programme to 
realise optimal clinical HIV treatment outcomes. 
In this chapter, the following concepts of the study are reviewed: definition of retention in care, 
retention in care in sub-Saharan Africa, retention in care in Southern Africa, retention in care in 
Swaziland and factors associated with retention in ART care. 
 
2.2 Definition of Retention in Care 
Retention is a critical component for both ART and PMTCT programmes to achieve optimal 
clinical HIV treatment outcomes such as improved survival rates, lowered the incidence of 
opportunistic infections, reduced HIV transmission and minimised possibilities of developing 
drug resistance. According to Patel et al. (2010:2), “Retention in care is the ability to adhere to 
critical aspects of care such as attending regular follow-up appointments, scheduled laboratory 
tests, and other monitoring activities according to health system standards and as prescribed by 
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a health care provider”. In addition, continuous engagement with the health facility is essential 
for one to be retained in ART care from initiation to lifelong ART (WHO, 2011).  
 
2.3 Retention in care and lost to follow up 
A patient is considered retained in care when they visit a facility within 90 days of their last 
scheduled appointment for medicine collection, laboratory testing, and/ or clinical review and is 
not documented as having died, stopped treatment, transferred out, or as lost to follow up 
(LTFU). LTFU is on the other extreme on retention in care spectrum. Patients LTFU may have 
unknown outcomes and LTFU rates point at gaps in knowledge and information systems (WHO, 
2011).  
A sample of LTFU patients traced actively by Geng et al. (2010b) revealed that 29% were 
deceased but not registered as dead at the health facility. Of the remainder, 10% were alive but 
no longer in care, 39% were alive and of unknown care status, and 51% were self-transfers to 
other health facilities. After incorporating the outcomes among the sample of lost patients into 
the entire clinic population, this study found that the corrected estimate of retention on ART at 
24 months rose to approximately 79% to 86%, as compared to 69% if all LTFU were considered 
as those not retained.  This therefore means that the corrected LTFU is obtained by factoring out 
all dead and transferred out patients including self-transfers.  
Studies have shown significant levels of LTFU on ART particularly during the first 1 to 2 years, 
largely due to death and silent, non-documented self-transfers (Yu et al., 2009; Maskew et al., 
2007). World Health Organisation (2011) supplements that LTFU can be distorted by 
unregistered transfers of patients to other facilities, alternative health beliefs and practices, 
provision of inaccurate personal information by patients, health service delivery issues and 
financial issues. For any programme to actively retain clients on ART and to be sure that patients 
are receiving the package of services as required, there is need to monitor and actively follow up 
patients who miss or default their appointments before they become LTFU. 
In addition, another study conducted in South Africa showed similar mortality rates for pregnant 
and non-pregnant women initiated on ART and a substantially higher 3-year LTFU rate in 
women initiated on ART during pregnancy women of 32% compared to 13% for non-pregnant 
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women (Toro et al., 2010). Similarly, Wang et al. (2011) identified pregnancy as a risk factor for 
LTFU in a cohort of adult men and women initiated on ART at community care sites. The 
potentially high attrition rates in cohorts of women initiated on ART during pregnancy call for 
better understanding of the factors associated with poor retention in care to ensure better 
programme retention. 
LTFU patients have been shown to have no viral suppression but have detectable, high viral 
loads (Krishnan et al., 2011). At high viral loads, the risk of HIV transmission is also high. If 
pregnant or lactating women have high viral loads, they predispose their partners and children to 
HIV infection. De Cock et al. (2000) approximate the rates of HIV transmission during 
breastfeeding at 10 to 15%. In Swaziland, women breastfeed for longer duration of about 2 
years; thereby further exposing their babies to HIV infection. 
 
2.4 Retention in care in sub-Saharan Africa 
Sub-Saharan Africa is home to just above two-thirds of PLHIV globally, and the number of 
people accessing antiretroviral treatment rose to about 10.7 million people in 2014 from fewer 
than 100,000 people in 2002 (UNAIDS, 2014). Whilst there is undisputable need to scale up 
provision of ART in sub-Saharan Africa, there is also need to closely monitor and ensure 
retention in care in the cohort of patients on ART.  
Poor retention in ART care occurring among PLHIV on ART in sub-Saharan Africa has been 
widely documented (Maskew et al., 2007; Boyles et al., 2011). In West Africa, retention in care 
has been reported as 76% by 12 months after ART initiation whilst in Southern Africa 12 months 
retention rates range from 67–70% in countries like Mozambique to 82.7% in Botswana 
(Bussmann et al., 2008; Lambdin et al., 2011). 
Poor long term retention in care has been identified as a major barrier to the success of ART 
programmes in Africa. A systematic review of ART programmes by Rosen and Fox (2010) in 
sub-Saharan Africa found that on average only 64% of patients are retained in care after two 
years of ART. LTFU is highlighted as the commonest cause of attrition, followed by death, 
which is often under-estimated in most sub-Saharan African countries. Another analysis in South 
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Africa of 44,177 patients accessing ART services in the public sector found about 71% and 
59.6% retention in care at 2 and 4 years after ART initiation respectively, with the proportion of 
LTFU patients increasing over time (Cornell et al., 2010).  
Efforts to further accelerate ART service coverage in sub-Saharan Africa through 
decentralisation of ART services to lower level health-care facilities and task-shifting of service 
provision to nurses have resulted in increased ART coverage, and improved adherence and 
retention in care (Boyer et al., 2010; Chan. et al., 2010; Fatti et al., 2010). However, there is 
limited data on retention throughout PMTCT interventions as well as longer-term retention on 
ART for women initiated on ART during pregnancy.  
 
2.5 Retention in care in Southern Africa 
Access to ART continues to increase in Southern Africa through decentralisation of ART 
services, task shifting and involvement of the community in the delivery of health care. 
However, long-term retention in ART care remains one of the major challenges to long-term 
survival with HIV infection (Rasschaert, Koole, Zachariah, Lynen, Manzi & Van Damme, 2012). 
The retention rates in the region are very similar to the sub-Saharan Africa rates as estimated by 
Fox and Rosen (2010) in a meta-analysis of published cohort data. For example, after pooling 
data in a random-effects meta-analysis, retention at 12 months was 80.2% compared to the 12 
month retention  of Zimbabwe, Zambia, Swaziland, Lesotho and Botswana that were found to be 
85%, 80%, 89%, 72% and 86% respectively (World Health Organisation, 2011). 
According to World Health Organisation (2011), retention in care in Southern Africa remains 
complicated as a result of an interplay of many factors. The identified factors influencing poor 
retention in ART care in Southern Africa include patient, provider, socio-cultural and health 
system factors. Most individuals and communities may later elect for traditional healers in 
preference to consulting with health care facilities (Mshana et al., 2006). These patients could 
eventually drop out from ART programmes and thus may become LTFU.  
A study conducted in South Africa found health system related factors such as financial 
challenges as the leading causes of LTFU in 34% of the patients on ART (Maskew et al., 2007). 
Other health system factors come into play when patients have high frequency of appointments 
 
 
 
 
9 
 
difficult for patients because of high transportation costs, consequences of missing work and 
home responsibilities. In addition, a significant proportion of patients are lost in care because of 
death, especially during the first year following initiation of ART. This is due to a significant 
proportion of patients who come presenting with advanced HIV infection (Mutasa-Apollo et al., 
2014). 
 
2.6 Retention in care in Swaziland 
Swaziland has operationalised appointment attendance definitions as kept appointment, missed 
appointment, defaulted and LTFU (Swaziland Ministry of Health, 2012a). Kept appointment is 
any visit to the facility 7 days prior to the appointment date to 3 days post appointment. Patients 
with missed appointments are those who get in contact with the facility 3 to 7 days after their 
appointment dates. Any patient who misses their facility appointment by more than 7 days, but 
less than 90 days is categorised as having defaulted. If a patient does not have any contact with 
the health facility for a period of at least 90 days, they become LTFU. The tools that are 
available for monitoring retention in care include: ART file, ART register, electronic ART 
medical records, appointment register and call logbooks. 
According to the Swaziland Ministry of Health (2014), the 6 months retention in care for adults 
on ART remains high at 96% and the 12, 24 and 36 months retention rates drop to 88%, 82% and 
78% respectively. The national 12 months retention rate for the adult population is 88% implying 
that there is a 12% attrition rate at 12 months after initiation of ART. In order for the country to 
realise optimal clinical HIV treatment outcomes, studies in resource limited settings have shown 
the need for sustained long term retention in care (Rich et al., 2012; Mutasa-Apollo et al., 2014).  
A considerable amount of data is routinely collected from the health facilities and serves the 
purpose of monitoring and evaluation. Regular reports are sent to the national level on the status 
of the national ART programme. Nevertheless, there is still limited data on retention in care for 
PMTCT interventions especially for women initiated on ART during pregnancy. Even after the 
adoption of lifelong ART for all HIV positive pregnant and lactating women, this aspect of care 
has received relatively little attention 
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2.7 Factors associated with retention in care 
There is a large and growing literature on factors associated with retention in care. Literature has 
identified a wide range of key factors and addressing these factors has been emphasised as an 
important element for clinical success at both patient and programme levels. However, most of 
the research has focused on the general population without elucidating the factors contributing to 
poor retention amongst women initiated on ART during pregnancy. Reiter et al. (2000) highlight 
a number of factors that are associated with retention in care for patients in PMTCT and ART 
programmes. These factors can be divided into the following five categories: patient variables, 
socio-economic, treatment regimens, disease characteristics, and health system related factors 
(Figure 2.1). Apart from treatment regimens, all patient and community barriers to adherence to 
treatment are also associated with retention in care (Patel et al., 2011). 
Patient variables include socio-demographic factors such as age, gender, race, income, 
psychosocial support, education, literacy, stigma and discrimination, and socio-economic factors. 
Several studies have elicited age as a risk factor for retention in ART care, albeit in contrasting 
ways. A study from Tanzania found that younger women are less likely to be retained in care 
than older women (Kirsten et al., 2011). In contrast, a multiple country study on retention on 
ART in Latin America found that poor retention increased by 6 percent with each one-year 
increase in age (Cohn et al., 2008). This means that increasing age can either increase or 
decrease the likelihood of retention in care depending on the setting.  
Some studies done in ART programmes in sub-Saharan Africa, show that male sex is associated 
poor retention in care (Stringer et al., 2006; Wang et al., 2011; Labhardt et al., 2013; Mutasa-
Apollo et al., 2014). Compared to females, males are poorly retained in ART care mainly 
because male HIV patients in sub-Saharan Africa have a higher probability than females to 
present with advanced HIV infection at ART initiation (May et al., 2010) and men have 
significantly higher rates of employment outside the home than women (Toro et al., 2010). In 
addition, Toro et al. (2010) also show that the retention of pregnant women in care was lower 
than that of non-pregnant women and men at 82% compared to 87% and 86% respectively at 30 
months of follow-up.  
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Figure 2.1: Conceptual Framework for Retention in Care 
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A systematic review of studies on retention in care in developing country settings reported the 
following socioeconomic factors: cost of transport, food insecurity and lower literacy as barriers 
to retention in care (Geng et al., 2010a). In addition, low financial income has been reported as a 
barrier in some studies done in sub- Saharan Africa (Hodgson et al., 2014). Income is needed for 
transport to the health facilities to pick the ARV supply and procure food. These indirect costs of 
ART and other spending while seeking care, serve as disincentives when the distances to the 
health facilities are long. Studies have shown that the direct and indirect costs of care affect the 
ability of PLHIV to remain in ART care (Siedner et al., 2013; Assefa et al., 2014).  
Lack of knowledge and misconceptions about HIV and its treatment have also been elicited as 
barriers to retention in care (Smith et al., 2012; Colvin et al., 2014). Similarly, studies included 
in the systematic review by Hodgson et al (2014) reported sufficient knowledge about HIV/ 
AIDS, ART, or need to protect one’s child and commitment to a child’s health as enhancers of 
retention in ART. The authors postulate that higher levels of education contributed to better 
health literacy, which in turn promoted retention in care. With sufficient knowledge, patients 
would always want to stay healthy, have healthy children and protect their partners from 
reinfection. In studies in Uganda, South Africa, and Tanzania, a lack of knowledge about health 
services or ART was identified as a barrier to ART retention (Duff et al., 2010; Watson-Jones et 
al., 2012). Similarly, the same finding was reported in pregnant women initiated on ART during 
pregnancy, before and after delivery. For example, a study done in Ghana found that the majority 
of the study participants had a high level of essential HIV knowledge on HIV and ART basics, 
and women with inadequate levels of knowledge on PMTCT and ART had a high likelihood of 
being poorly retained in care (Boateng, Kwapong & Agyei-Baffour, 2013). 
Disclosure of HIV status with associated stigma and discrimination are other patient 
characteristics that have been associated with poor retention in care in studies across sub-Saharan 
Africa (Arrive et al., 2012; Hodgson et al., 2014). A study in Kenya by Ujiji et al. (2011), 
reported that fear of negative consequences by partners was associated with poor retention in 
care. The negative consequences include domestic violence, divorce and blame for bringing HIV 
into the family. It is possible that women who choose to disclose to their partners already have 
positive and supportive relationships with their partners, and that these positive relationships in 
themselves promote ART retention. Furthermore, nondisclosure of HIV status in fear of 
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stigmatisation by family members or the community can result in lack of psychosocial support 
and consequently poor retention in care.  
Other behavioural determinants of retention in care that have been associated with retention in 
care are physical impairments and substance abuse. For instance, Smith et al. (2012) in a mixed-
methods qualitative analysis reported that drug abuse and / or alcohol consumption could mask 
the need for HIV care resulting in poor retention in care. The internalised stigma related to 
substance abuse resulting from self-shame or anticipated judgment from providers, discourages 
patients from continuing with their ART care attendance. In addition, individuals who smoke 
cigarettes were reported to have a high likelihood of becoming LTFU (Krishnan et al., 2011). 
The treatment regimen related determinants of retention in ART care include adherence, 
tolerability, and toxicity profiles of ART, the number of pills prescribed, the complexity of the 
regimen and the specific type of ARVs (World Health Organisation, 2003).  
Retention in care is an important aspect of ART, but at times less recognised. To achieve high 
rates of retention in ART and favourable HIV treatment outcomes for patients in the PMTCT and 
ART programmes, adherence to therapy remains an important component (Makunde et al., 
2012). Adherence measures the percentage of patient behaviour to a prescribed therapy. In 
contrast, retention in care measures the duration during which a patient remains on a prescribed 
therapy. However, achieving sustained retention in care and having optimal ART adherence with 
ART have proven to be difﬁcult and may have more challenges than with many non-
communicable diseases ( Bae, Guyer, Grimm & Altice, 2011). This could be due to HIV-related 
stigma – a signiﬁcant barrier to retention in care, dosing schedule and the complex treatment 
regimens that may also have undesirable adverse effects and other drug interactions. Effective, 
one pill and once daily potent ARV regimens with minimal toxicities or drug interactions have 
significant positive impact on adherence and consequently retention in care. 
Other barriers of retention in care include the ART regimen (Velen et al., 2013). This could be 
due to the toxicity, dosing frequency or complexity of the regimen causing patients to abandon 
ART. Similarly, a systematic review by Gourlay et al. (2013) revealed that the type of ARV 
regimen taken during pregnancy influenced maternal adherence and that women taking twice-
daily regimen were less likely to adhere than women taking once-daily regimen. On the 
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recommendation of WHO, many countries in sub-Saharan Africa have opted for Zidovudine or 
Tenofovir based triple fixed dose combinations (WHO, 2013), but poor retention remains a 
challenge. This shows the complexity of retention in care and the need for further research to 
elicit the determinants of poor retention especially amongst women initiated on ART during 
pregnancy. 
Disease characteristics factors include WHO clinical stage, duration of HIV infection and 
associated opportunistic infections. Several studies have found the following barriers to retention 
in care; advanced HIV infection (Toro et al., 2010; Thida et al., 2014; Mutasa-Apollo et al., 
2014), low baseline CD4 cell count (Wang et al., 2011; Labhardt et al., 2013), low body weight 
at ART initiation (Mutasa-Apollo et al., 2014). Most patients with advanced HIV infection may 
be too sick to come to the health facility and are more likely to be lost in care due to death. In 
addition, DiMatteo (2004) cited disease characteristic factors affecting retention in care from a 
different perspective by looking at HIV infected adults with other chronic diseases such as 
psychiatric conditions. Similarly, other studies in resource limited settings have reported 
comorbidities such as mental health (Sherer et al., 2002; Geng et al., 2010a) and diabetes 
(Giordano et al., 2007; Patel et al., 2011) to influence poor retention in care. 
Studies have shown that women initiated on ART during pregnancy have a significant survival 
advantage although they are at greater risk of becoming LTFU (Wang et al., 2011; Boyles et al., 
2011). This is mainly because pregnant women are twice as likely to present early compared to 
non-pregnant women (Dourado et al., 2014). HIV positive pregnant women usually present for 
ART initiation when they are still stage 1 or 2 (Toro et al., 2010). Although advanced HIV 
infection has been associated with poor retention, paradoxically pregnant with advanced 
infection are retained better than those in HIV clinical stage 1 and 2 because majority of pregnant 
women have never been sick with HIV infection and may take ART for granted. Generally, sick 
pregnant women come back to the health facility because they need more attention whereas those 
who have never been sick never come back and never realise the benefits of early ART initiation. 
Therefore, improved retention in care is a prerequisite for women initiating ART early during 
pregnancy to realise optimal clinical HIV treatment outcomes. 
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Other disease characteristic factor that has been associated with retention in care is CD4 cell 
count level. Some cohort studies have shown the association of low CD4 cell count with poor 
retention in ART care (Giordano, 2011). This finding reinforces the crucial importance of early 
HIV diagnosis and timely initiation of ART in the broader perspective of increasing survival 
rates. Similarly, another retrospective study by Thida et al. (2014) singled out baseline CD4 cell 
count less than 100 as a barrier to retention in care. This could be due to the high mortality in 
patients with advanced HIV infection. 
According to Harries, Zachariah, Lawn and Rosen (2010), an ART programme can be used as an 
opportunity to improve holistic linkages and provide additional services such as family planning, 
nutritional assessment, counselling and support, which in return may encourage better retention 
in care.   
Health system factors can be divided into patient-provider relationship related and clinical setting 
factors. The patient-provider relationship factors includes the patient’s overall satisfaction and 
trust in the provider and clinic staff, the patient’s opinion of the provider’s competence, the 
provider continuity, the provider’s willingness to include the patient in the decision making 
process and the effectiveness tone of the relationship as exemplified by warmth, openness and 
cooperation of the caregiver (Sihvonen,  Käyhkö & Kekki, 1989). 
A qualitative descriptive exploratory study by Duff et al. (2010) found that optimal provider-
patient interactions enhance retention in care. The more the provider interacts with the patient, 
the more the patient trusts the provider and clinic staff in general, and the more likely the patient 
is retained in care. During the interaction, the provider may also include the patient in the 
decision making process to improve the overall satisfaction and foster patient ownership of their 
treatment. Patient satisfaction may also come from the provision of health services tailored to the 
needs of patients. A literature review by Sherer et al. (2002) concluded that patient satisfaction 
leads to better health outcomes and retention in care.  
Other factors that enhance retention in care include provider continuity (Smith et al., 2012; 
Siedner et al., 2013) and use of peer support groups (Sherer et al., 2002). Provider continuity 
nurtures patient trust to the provider and confidence in accessing the service thereby promoting 
persistence in care. Psychosocial support can be support from the available support structures 
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such as support groups that help in attending to scheduling conflicts, facilitating appointment 
reminders, or accompanying one to an appointment thereby encouraging retention in care. Some 
cross-sectional and nonrandomised studies of HIV-infected persons in care have shown that 
access to social services, and flexible clinic hours are associated with retention in care (Giordano 
et al., 2007). Flexible clinic hours help in reducing waiting hours, which in turn encourage 
patients to continue coming to the health facilities to pick up their ARVs. 
Kalogianni (2011) adds the clinical setting related factors, which influence retention in care. 
These factors include; distance to the clinic, general environment, system of appointment, 
facility staff attitude and training of staff on ART. A mixed methods study conducted in Ethiopia 
elicited long distance to the ART clinic as a barrier to retention in care (Assefa et al., 2014). 
Similar results were found in rural Uganda and Malawi (Tuller et al., 2010; Yu et al., 2009). 
Distance to the clinic has a direct bearing on the cost of travel, which serve as a disincentive 
when the distances to the health facilities are long and consequently result in poor retention in 
care. 
An enabling environment is required to support retention in care through stigma reduction, 
strengthened capacity to provide, support and promote linkages and access to prevention, care 
and support (WHO, 2011). Otherwise, a fragmented health care system often forces PLHIV to 
obtain care through multiple delivery systems, making it difficult to coordinate and attend 
appointments thereby leading poor retention in care. 
Other clinical setting factors associated with retention in care include the system of appointment 
(Mwatawala et al., 2012; Chalker et al., 2013), facility staff attitude (Gerbert et al., 1991; Smith 
et al., 2012), and lack of proper training of staff on ART (Assefa et al., 2014; Rollins et al., 
2015). If health care workers have a bad attitude, acting unprofessionally, patients are more 
likely to be discouraged from persisting in care. Studies have shown that women, especially, are 
less likely to participate in programmes if health care workers have negative attitudes (Gerbert et 
al., 1991). Systems of appointment that involve the patients, allow less frequent visits and are 
flexible have been reported to encourage patient retention in care (Giordano et al., 2007). 
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Summary 
Retention in care remains a key element in maximising the efficacy of ART in improving 
survival rates of HIV/AIDS patients, lowering the incidence of opportunistic infections, reducing 
MTCT and minimising the possibilities of developing drug resistance. Hence, the recent global 
efforts through the 90-90-90 initiative to have at least 90% of the PLHIV knowing their HIV 
status, 90% of the HIV positive people linked and retained on ART, and 90% of the people on 
ART having their viral load suppressed by 2020. Poor retention in care has been noted among 
pregnant women and little is known about the factors that influence persistence in care among 
women initiated on ART during pregnancy. Identifying factors that influence retention in care is 
an important process in designing interventions aimed at sustaining long-term retention in care. 
The next chapter outlines the methodology used to achieve the specific objectives.  
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3 METHODOLOGY 
3.1 Study design 
 
A quantitative, retrospective cohort study design was used (Ho, Peterson & Masoudi, 2008). 
Data was collected using a data extraction sheet (Appendix 1) from 316 clinical records of 
women who were initiated on ART during pregnancy within the defined period. Using this study 
design, records of pregnant women initiated on ART during pregnancy were abstracted for 
different exposures and outcome for the study that had already happened. Data on patient 
variables, treatment regimens, disease characteristics and health system related factors were 
abstracted for the study and LTFU was the endpoint. The direction of study was retrospective. 
Using the retrospective design the outcome of interest– retention in care – has already happened. 
This serves time and reduces all logistical and travelling costs. The design establishes the 
temporal relationship between different exposures and the outcome, thus ensuring that the 
measurement of the exposure is not biased by the outcome and reducing the likelihood that an 
association is cause and effect (Ho, Peterson & Masoudi, 2008). 
 
3.2 Study Setting 
The study was conducted at one of the busiest PHUs in Swaziland, King Sobhuza II PHU. PHUs 
are departments of the hospitals and health centres, which offer Maternal and Child Health 
services. Swaziland has integrated HIV care and treatment services in the PHUs (WHO, UNFPA, 
UNAIDS & IPPF, 2011). 
King Sobhuza II PHU provides a range of services such as dental clinic, sexually transmitted 
infections clinic, skin clinic, antenatal clinic, post-natal clinic, family planning clinic, child 
welfare clinic, outreach services and ART services. PMTCT services started in 2003 (WHO, 
UNFPA, UNAIDS & IPPF, 2011). With assistance of Elizabeth Glaser Paediatric Foundation in 
2007, HIV care and treatment services were integrated in the setting and the facility offers ART 
services to pregnant women, lactating women and their families.  
The PMTCT programme follows national guidelines for ART initiation and used Zidovudine, 
Lamivudine and a non-nucleoside reverse transcriptase inhibitor as first-line regimen, and 
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protease inhibitor based regimens for second line regimen. In 2015, the national guidelines were 
updated in accordance to 2013 WHO recommendations and Swaziland adopted Tenofovir, 
Lamivudine and Efavirenz, the once daily regimen as the preferred first line regimen (Swaziland 
Ministry of Health, 2015). The move from a twice daily regimen to a once daily regimen was 
implemented to improve adherence and retention in care among women initiated on ART during 
pregnancy. 
 
3.3 Study Population and Sampling  
The study population was women who were initiated on ART during pregnancy at King Sobhuza 
II PHU from January 2012 to December 2013 and were followed up to the end March 2015. The 
study participants were identified using the ART registers and the electronic database. All 
patients meeting the inclusion criteria identified from the ART register or electronic database had 
their ART chronic file retrieved for data abstraction.  
The exclusion criteria include the following women; women who were initiated on ART during 
pregnancy but were transferred out from the facility, those women who initiated treatment during 
pregnancy but miscarried, died or had an abortion whilst on ART. Of the 372 women who were 
initiated on ART during pregnancy, 2 who had miscarriages and 54 were transferred out from 
King Sobhuza II PHU to other health facilities and were excluded from the study as shown in 
Figure 3.2 below. 
The inclusion criteria included all women who started ART during pregnancy and had term 
delivery. At the end of the recruitment process, 316 files were reviewed and analysed for the 
study. Caution was taken to identify all study eligible patients as listed in the ART register and 
were verified by the available electronic database at the study site to ensure that all eligible ART 
initiated pregnant women were included in the sampling frame. 
 
 
 
 
 
 
 
20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Recruitment process for the study participants 
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3.4 The Pre-test of Data Abstraction Tool 
The data extraction tool was pretested in 15 patients at Raleigh Fitkin Hospital to ensure its 
validity and reliability. The pre-test was done to check for any hidden cognitive and 
communicative biases that the investigator was not aware of. Pretesting of the data abstraction 
tool allowed for the identification of any source of bias. The purpose was to identify the sources 
of measurement bias that could have been detrimental to the actual data abstraction. Refinement 
of the instrument was then done with a focus of minimising measurement error. Some questions 
were added to the abstraction tool. Some questions were eliminated.  
 
3.5 Data Collection  
Data was collected from the 1
st
 of April to the 30
th
 of April 2015 for all women who fitted in the 
inclusion criteria for the study period. The investigator developed a data extraction sheet which 
was used to abstract all the required information from the patient files (Appendix 1). The 
variables extracted included patient, socio-economic, treatment regimens, disease characteristics 
and health system related factors. Unlike prospective cohort studies, in which the investigator has 
control over what exposure variables and outcomes are measured, the flexibility is not possible 
in retrospective cohort studies because the documentation of variables has already happened. The 
investigator was limited to the variables documented in the patient files and / or captured in the 
electronic system.  
Retention in the ART programme was defined as a visit to the health facility for a scheduled 
clinic or ART refill visit at least once in the past 3 months. For the survival analysis, the “event” 
of interest was LTFU leading to discontinuation from the ART programme. Patients retained in 
care were censored at their latest date of last clinic or ART refill visit (“last ART visit date”). 
Women who did not come to the clinic during the last 3 months, and were not transferred out and 
did not die were considered as LTFU from the ART programme (“event”). As discontinuation 
(“event”) time, the last date of clinic or ART refill visit was used. Variables were abstracted on 
the date of ART initiation for variable at ART initiation, and some variables were abstracted on 
the last ART visit date for both LTFU patients and those retained in care. For all patients, the last 
ART visit date was the latest date of ART refill visit after ART initiation.  
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Patient variables 
The patient variables extracted included age, level of education, patient weight and body mass 
index (BMI) at ART initiation, patient weight and BMI on the last ART refill visit. Swaziland 
has a different education system after primary education, form 1 to 3 is secondary education and 
form 4 and 5 constitute high school. After high school, one then enrols for tertiary education. 
The investigator used the patient reported and health provider calculated age from the given date 
of birth at ART initiation as recorded in the medical records. In the patient file, there is a field on 
level of education and this is the highest level of education attained by the day of ART initiation. 
Patient weight and height were abstracted as recorded in the records on the day of ART initiation 
and on the last ART refill visit. Additionally, the BMI was calculated using the weight and 
height as documented in the file.  
Socio-economic variables 
Socioeconomic variables were as follows; marital status at ART initiation, disclosure to the 
partner at ART initiation, reported consistent condom use at ART initiation, partner status known 
at ART initiation, and HIV positive partner known to be on ART by the time the woman initiates 
ART. The facility staff routinely documented marital statuses of patients in the records. During 
the psychosocial assessment of patients before ART initiation, the following variable were 
captured into the records; whether disclosure was done to the partner, whether the woman 
consistently used a condom during sexual encounters with the partner and whether the partner is 
on ART. 
Treatment regimens variables 
Treatment regimen related variables included ART regimen initiated, changes in regimen after 
initiation, family planning use after delivery, any reported side effects whilst on ART and any 
reported poor adherence after ART initiation. The file had different options of ARV regimen and 
the health care worker would check the applicable regimen initiated to the patient. If for any 
reason the regimen was changed, then the new regimen would be documented on the given date 
of visit. The records had a field to document the family planning option the woman was taking 
on every visit and of interest was family planning used after delivery. After patients were started 
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on ART, records were searched for any reported and documented side effects and poor 
adherence. Patients were encouraged to take their medication same time(s) every day and pill 
count was done. On every visit the extent to which the patient was taking medication as 
prescribed medication by the health care provider was calculated, expressed as adherence rate 
and documented on each visit. Poor adherence was defined as any adherence rate less than 95% 
including missed and defaulted appointments. The data was carefully abstracted for any history 
of poor adherence by checking the adherence levels on every visit as documented in the records.  
Disease variables 
The disease characteristic variables abstracted were duration between HIV testing and ART 
initiation, presence of comorbidities at ART initiation, HIV clinical stage, previous PMTCT 
received by the woman, baseline CD4 cell count, number of CD4 cell counts done and trend of 
CD4 cell counts. The dates of HIV testing and ART initiation were routinely documented in the 
patient records. The duration between HIV testing and ART initiation were then calculated using 
the two variables. On ART initiation, health care workers were expected to obtain a 
comprehensive history, examine all patients and document the findings. History taken includes 
demographic, presenting complaint, past medical history, drug history, social and family history. 
On examination, the following findings are elicited; weight, height and findings from different 
systems. It is then from such findings that a patient is staged clinically based on the WHO 
clinical staging. In addition, any comorbid diseases and history of previous PMTCT were 
required to be documented in patient records accordingly. The CD4 cell counts done before ART 
initiation were documented and then abstracted as baseline CD4 cell counts. The number of CD4 
cell counts done included all CD4 cell count done for the duration of ART and the baseline CD4 
cell count. Furthermore, the trend of CD4 cell counts was then analysed and abstracted 
accordingly.  
Health system variables 
Health system related variables included documentation of other baselines laboratory 
investigations and distance to the facility. Documentation and interpretation of other baselines 
which included at least one of the following: the haemoglobin levels, the liver function tests and 
renal function tests. Distance from the patient’s home to the clinic was estimated using distance 
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from the recorded address to the clinic. The other health system related factors such as general 
environment, system of appointment, facility staff attitude and training of staff on ART were not 
documented in the patient records and were assumed to be constant since the study was 
conducted in one health facility. However, further studies are recommended to investigate these 
factors in women initiated on ART during pregnancy. 
For all data collection, the investigator completed a data extraction sheet. All variables were 
obtained from the study patients’ medical records that included the individual patient files and 
the electronic records. The investigator then summarised the information from the data extraction 
sheet electronically using an excel sheet. 
 
3.6 Data management and analysis 
 
The data extraction sheets were completed onsite and checked for completeness before the 
investigator departed from the health facility. Reasons were given for any incomplete files. 
Names of study participants were not recorded. Instead, unique identification numbers were used 
for purposes of data analysis. As discussed in the data collection section, data extraction sheets 
were kept in a locked place where only the investigator was able to access the files. 
Every effort was made to abstract all available data. Unless explicitly stated otherwise, missing 
data were not be imputed. Data were analysed and presented as they were recorded in the 
database. In calculating dates, estimated dates were as follows; for partial start dates, if the 
month or year was unknown, then the date were not imputed and were assigned a missing value. 
If only the day was unknown, and if only the month and year match the month were available or 
the year only, then the day of the date were imputed; otherwise, the date was imputed as the first 
day of the month. In addition, missing any clinical/ immunological assessment data were not 
imputed. 
The first step to data analysis was to prepare and organise data. Data was summarised on an 
Excel sheet. All responses to questions summarised on an excel sheet were coded accordingly. 
Data cleaning and sample duplicate data entry was used to assure data quality. The dataset was 
imported into IBM SPSS Statistic 20 Software for analysis. 
 
 
 
 
25 
 
Summary statistics were presented to give a general description of the patients studied and an 
overview of the patient characteristics, clinical factors, and factors associated with retention in 
care. All analysis tables were summarised for all patients accordingly. Categorical variables were 
summarised as the number and percentage of participants in each category. Continuous 
parameters were summarised using numbers, mean, standard deviation (SD), median, minimum 
(min), and maximum (max) values. 
Type I error rate () for statistical tests was set at 0.05 and 95% confidence intervals (CI) were 
provided when appropriate. P-values were reported to three decimal places with a leading zero 
(0.001). P-values of 0.000 were reported as <0.001 and not 0.000. All percentages and means 
were reported to one decimal place, standard deviation reported to two decimal places and min 
and max values to the same decimal places as the original data are recorded.  
A descriptive analysis of all pregnant women who were initiated on ART within the specified 
period; those who defaulted before delivery; those retained in care and those lost in care after 
delivery was done. Of all the women initiated on ART during pregnancy, the study is eliciting 
the time at which those not retained are getting lost from care. Some women would get lost 
before they deliver whereas some would get lost after delivery. Assessment of any significant 
differences characteristics were conducted using an analysis of variance (ANOVA) model or a 
chi-square test for continuous and categorical data, respectively, Frequency distributions and 
cross tabulations of all variables were generated.  Bi-variate analysis was done to determine 
significant associations between the dependent variable – retention in ART care at ART 
initiation and on the last ART refill visit – and the independent variables. Chi-square test (2) 
statistics, p-values, odds ratios (OR) and 95% confidence intervals (CI) were computed to show 
the statistically significant variables. Furthermore, survival analysis including Kaplan-Meier 
analysis was used to estimate cohort survival functions at 6 months, 12 months, 24 months and 
36 months. A proportional hazards model was fitted assuming a Weibull distribution for the 
survival time. The following statistics were computed; hazard ratio, 95% CI and the p‐value. 
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3.7 Validity and reliability 
 
There were challenges in the study design that could alter the study results. The investigator 
designed the data abstraction tool. Variables were modified and customised in consultation with 
colleagues from the National ART programme, facility sister in charge and some nurses working 
in the PHU.  
The data extraction tool was pretested in 15 patients at Raleigh Fitkin Hospital to ensure its 
validity and reliability. The pre-test was done to check for any hidden cognitive and 
communicative biases that the investigator was not aware of. Pretesting of the data abstraction 
tool allowed for the identification of possible source of bias. The purpose was to identify the 
sources of measurement bias that could have been detrimental to the actual data abstraction. 
Refinement of the instrument was then done with a focus of minimising measurement error. 
Some questions were added to the abstraction tool while some questions were eliminated. No 
inter-rater reliability was checked since there was one data abstracter.  
Selection bias was addressed by using the list of patients as it appears in the ART register at the 
PHU on the data collection days as the sampling frame, and using all records of study eligible 
patients as the study sample. Chance was further reduced by using the maximum possible sample 
size. 
The PHU ART register had a lot of missing data. However, triangulation of data sources such as 
the chronic care file and the electronic database was used. All missing data on the independent 
variables were documented but not imputed. There was likelihood that the data sets with missing 
variables could introduce a hidden bias which had a positive or negative effect on the outcomes 
of interest. To minimise this bias, missing values for both numeric and character variables were 
explicitly labelled as missing in tables and data listings. 
The natural interpersonal variability was eliminated by having the investigator as the only person 
abstracting data. The researcher played an important role to ensure the integrity of data 
throughout the course of the study. Every effort was made to abstract all available data, ensured 
data were recorded exactly as intended and hard copies secured in a lockable cabinet where only 
the researcher had access. A password was created to login and gain access to data in the 
database. 
 
 
 
 
27 
 
 There are unmeasured confounders that may affect the findings of this study. These included the 
level of competence and experience of the HCWs filling in the patient medical records. One 
would assume that the more experienced the HCW is, the fewer the errors that would occur. To 
ensure reliability and determine the quality of data abstraction, the investigator abstracted all data 
and reassessed 10 % of the sample of all patients initiated on ART. 
 
3.8 Generalisability  
 
The results of this study could apply to the study population. Nonetheless, it is anticipated that 
the findings will have relevance more broadly. The purpose of this study was not to extrapolate 
to the population at large but to provide an insight into the magnitude of poor retention in women 
initiated on ART during pregnancy and identify some of the factors associated with poor 
retention in care.   
 
3.9 Ethics considerations 
 
The Senate Higher Degrees and Research committees of the University of the Western Cape 
reviewed and approved the study protocol. In addition, the King Sobhuza II PHU authorities 
granted the permission to access data in the PHU. The study had no explicit risks to the study 
subjects and its findings were to inform processes for improving the retention of patients in ART 
programmes especially in HIV positive women who initiate ART during pregnancy. Unique 
identification numbers instead of names were abstracted using the data extraction sheet. 
Furthermore, careful measures were taken to treat patient records with confidentiality; ensuring 
that information collected was used only for that study, removing personal identifying 
information from data extraction sheet and computer files, and making sure that no identifiable 
data was published. All data records were kept in lockable box files for safety and confidentiality 
during data collection and analysis. 
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4 RESULTS 
During the study period, 316 records of women who were initiated on ART whilst pregnant were 
recruited at King Sobhuza II PHU in Swaziland. During the analysis all records were used.  
4.1 Patient characteristics 
After the analysis, the independent variables were further classified into patient variables, socio-
economic, treatment regimens, disease characteristics and health system related factors. The 
patient variable included the demographic data – age, marital status and relationship with 
treatment supporter.  
The age of the women initiated on ART during pregnancy ranged from 16 – 45 years (Figure 
4.3). The median age was 26 years (IQR: 23 – 30) and the mean age was 26.92 (SD= 4.86) years. 
 
Figure 4.3: Age distribution of the study participants 
 
At ART initiation, 61.7% of the pregnant women initiated on ART were single and the 
remainder, 38.3% were married. Of the 316 women who participated in the study, 81.7% of the 
women attained at least secondary education while 2.2% and 16.1% of the women had no 
education at all and attained only primary education respectively. Table 4.1 below summarises 
the socio-demographic characteristics of the study participants. 
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Table 4.1: Socio-demographic characteristics of pregnant women initiated on ART (n=316) 
 Frequency  Percentage (%) 
Age (in years) 15 – 24 109 34.5 
 25 – 34 186 58.9 
 35 – 44 20 6.3 
 > 45 1 0.3 
Marital Status Married 121 38.3 
Single 195 61.7 
Level of Education None 7 2.2 
 Primary 51 16.1 
 Secondary 134 42.4 
 High School 89 28.2 
 Tertiary 35 11.1 
Employment Status 
 
Employed 129 40.8 
Unemployed 186 58.9 
Missing 1 0.3 
Relationship with treatment 
supporter 
Husband 103 32.6 
Boyfriend 21 6.6 
Mother 108 34.2 
Sister  46 14.6 
Aunt 14 4.4 
Daughter 1 0.3 
Father 7 2.2 
Other 16 5.1 
Distance to the Health facility < 5 km 174 55.1 
6 – 10 km 73 23.1 
11 – 15 km 33 10.4 
> 16 km 36 11.4 
Reported financial challenges at 
ART initiation 
Yes 48 15.2 
No 265 83.9 
Missing 3 0.9 
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More than half (186/316) of the participants were unemployed. In addition, all the study 
participants had treatment supporters with 32.6% and 34.2% reporting their husbands and 
mothers as treatment supporters, respectively.  
Geographically, more than half of the patients (174/316) stayed within a 5 km radius while 
11.4% reported that they had to travel over 16 km from their homes to the PHU. The median 
distance was 5.0 km (IQR: 4 – 9) while the maximum distance travelled by one woman was 90 
km. The majority (83.9%) of participants reported no financial challenges and could afford to 
come to the facility for their ART refills as recommended by the facility staff and thus, retained 
in care.  
As shown in Table 4.2 below, the majority (86.7%) of the women were eligible for ART based 
on CD4 cell count less than 350. Only a single patient initiated on ART had a CD4 cell count 
above 500. The median estimated gestational age (EGA) at ART initiation was 24 weeks (IQR: 
18 – 31) with 6% and 60.8% of the patients being initiated on ART in the 1st and 2nd trimester 
respectively.  
Of the patients coming in with a known positive status, 62.9% had taken a PMTCT regimen, 
short course Zidovudine, intra-partum dose and the tail (Under Option A of the 2010 WHO 
Guidelines). Disclosure levels remains very low with 45.6% of the women being initiated on 
ART without disclosing their status to their partners.   
Swaziland National ART programme rolled out the 2010 Guidelines to all facilities in the 
country. With the 2010 Guidelines, the preferred first line for pregnant women was Zidovudine, 
Lamivudine and Nevirapine but with new evidence coming from WHO, Efavirenz and Tenofovir 
have been found to be safe in pregnant women. From June 2012, the facility started to give 
Tenofovir and Efavirenz to pregnant women although it had not been adopted as part of the 
National Guidelines. More than three quarters of the study participants were initiated on 
Zidovudine, Lamivudine and Nevirapine and less than 30% were initiated on Tenofovir based 
regimens.  
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Table 4.2: Clinical characteristics of pregnant women initiated on ART at King Sobhuza II PHU 
(N=316) 
 Frequency  Percentage (%) 
Baseline CD4 < 200 86 27.2 
201 – 350 188 59.5 
351 – 500 41 13.0 
> 500 1 0.3 
Estimated Gestational Age at ART 
initiation  
1
st
 Trimester 19 6.0 
2
nd
 Trimester 192 60.8 
3
rd
 Trimester 105 33.2 
Previous PMTCT Yes 56 17.7 
No 33 10.4 
N/A 227 71.8 
Disclosure of HIV status to partner 
at ART initiation 
Yes 170 58.3 
No 144 45.6 
Missing 2 0.6 
Regimen AZT + 3TC + NVP 251 79.4 
TDF + 3TC + EFV 59 18.7 
Other 6 1.9 
Changes of regimen Yes 33 10.4 
No 283 89.6 
Consistent condom use at ART 
initiation 
Yes 207 65.5 
No 109 34.5 
Other family planning use on the 
last ART refill visit 
None 127 40.2 
Oral 39 12.3 
Injectable 99 31.3 
IUCD 1 0.3 
Tubal ligation 2 0.6 
N/A 48 15.2 
Weight changes on ART on the last 
ART refill visit 
Weight gain 80  25.7 
Weight loss 184  59.2 
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 Frequency  Percentage (%) 
No change 47  15.1 
Body mass index at initiation Underweight 1 0.3 
Normal 103 32.6 
Overweight 125 39.6 
Obese 83 26.3 
Missing 4 1.3 
Body mass index on the last ART 
refill visit 
Underweight 8 2.5 
Normal 118 37.3 
Overweight 113 35.8 
Obese 68 21.5 
Missing 9 2.8 
Timing of being LTFU Before delivery 39 47.6 
 After delivery 43 52.4 
 
 
After ART initiation, 89.6% of the women maintained their ART regimen and no changes were 
made to the ART regimen. However, 10.4% of the women had side effects such as anaemia 
secondary to AZT with led to the substitution of the offending drug from the ART regimen.  
At ART initiation, only 32.6% of the women had normal BMI as compared to 37.3% on the last 
ART visit. The occurrence of underweight in the women of childbearing age during and after 
delivery was found to be very low at 0.3% and 2.5% respectively. Reported condom use was low 
with only 65.5% reporting consistent condom use at the time of ART initiation. On the last ART 
visit date, 84.8% of the study participants were eligible for family planning with only 0.6% 
choosing permanent surgical methods and 12.3% and 31.3% opting for oral and injectable 
methods respectively. The majority of women (40.2%) opted not to be on any family planning 
after delivery. 
Of the 316 women who were initiated on ART during pregnancy, 52.4% became LTFU after 
delivery and 47.6% before delivery.  Figure 4.4 below shows the timing of becoming LTFU. 
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Figure 4.4: Timing of LTFU 
 
4.2 Factors associated with retention in care 
 
The overall retention rate at the PHU for the women initiated on ART during pregnancy after a 
median duration on ART of 25.80 months (IQR: 16.70 – 30.98) of follow up was found to be 
74.1% (n=316). The overall retention in care was calculated for women who had been on ART 
for a total duration of up to 39.4 months. The mean duration that the women had been on ART 
was 22.84 (SD = 11.61) months. Approximately 67.7% (214/316) of the participants had been on 
ART for at least 20 months. However, 9% (n=316) of the women became LTFU by 2 months. At 
6 months on ART, the LTFU rate was 16.5% (n=316); but rose slightly to 20.9% (n=316), 23.5% 
(n=243) and 26.9% (n=52) at 12, 24 and 36 months respectively.  
As shown in Table 4.3, the statistically significant risk factors for retention in care at ART 
initiation included; the estimated gestational age (p<0.001). Pregnant women initiated on ART 
during the early weeks of pregnancy were retained better that those initiated close to delivery. In 
addition, women with shorter duration between testing for HIV and ART initiation were retained 
better than those delaying ART initiation. However, duration between HIV testing and ART 
initiation was not significant (p=0.169).  
47.6% 
52.4% 
Before Delivery
After delivery
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Retention rates were lowest in women having one child at 66.4% followed by those with 4 
children at 71.4%. Pregnant women initiated on ART with more than 5 children were all retained 
in care.  Nonetheless, parity at ART initiation was not significantly associated with retention in 
care (p=0.153). Gravidity was also not significantly associated with retention in care 
(p=0.159).Other factors at ART initiation such distance to the facility, weight, baseline CD4 cell 
count and BMI were found to be not significant. 
On the last ART visit, the factors associated with retention in care were regular CD4 cell counts 
done for ART monitoring (p<0.001). Those who had regular CD4 cell count every 6 months 
were more likely to be retained in care than those who did not have CD4 cell count regularly. 
Other factors such as BMI on last ART refill visit, duration on ART, weight on last ART refill 
visit, number of CD4 cell count done were found to be not statistically significant. 
 
Table 4.3: Predictors of retention in care for women initiated on ART during pregnancy 
(ANOVA) 
  p-value 
On the ART initiation visit date   
             Estimated Gestational Age   <0.001* 
             Parity   0.153 
             Gravida  0.159 
             Distance from the facility  0.886 
             Weight   0.709 
             Baseline CD4   0.193 
             BMI  0.236 
             Duration from testing to ART initiation  0.169 
On the last ART visit date   
             BMI on last ART refill visit  0.387 
             Duration on ART  <0.001* 
             Weight on last ART refill visit   0.261 
             Number of CD4 cell counts done for ART monitoring   <0.001* 
* Significant at 5% 
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Table 4.4: Predictors of retention in care for women initiated on ART during pregnancy (Bi-
variate Analysis) 
 Number retained in Care (%)  p-value 
Age (in years) 
     15 – 24 
     25 – 34 
     35 – 44 
     45+ 
 
69 (63.3%) 
147 (79.0%) 
17 (85.0%) 
1 (100.0%) 
 0.014* 
Level of Education  
     None 
     Primary 
     Secondary 
     High School 
     Tertiary 
 
4 (57.1%)  
39 (76.5%)  
96 (71.6%)  
65 (73.0%)  
30 (85.7%) 
 0.389 
Marital Status  
     Married 
     Single 
 
100 (82.6%) 
134 (68.7%) 
 0.006* 
Employment status    
     Employed 
     Unemployed 
 
101 (78.3%)  
133 (71.5%) 
 0.096 
Distance from the facility  
     </= 5km 
     6 - 10km 
     11 - 15 km 
     >/= 16 
 
125 (71.8%) 
56 (76.7%) 
23 (69.7%) 
30 (83.3%) 
 0.448 
Baseline CD4 
     </= 200 
     201 – 350 
     351 – 500 
     > 500 
 
58 (67.4%)  
143 (75.7%)  
32 (80.0%) 
1 (100.0%) 
 0.348 
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 Number retained in Care (%)  p-value 
Duration from testing to ART initiation 
     </=90  
     > 90 
 
129 (72.5%)  
103 (76.3%) 
 0.444 
Regimen  
     AZT+3TC+NVP 
     TDF+3TC+EFV 
     TDF+3TC+NVP 
 
197 (78.5%) 
34 (57.6%) 
3 (50.0%) 
 0.002* 
Presence of other co-morbidities 
     No  
     Yes 
 
224 (74.4%) 
10 (66.7%) 
 0.504 
Clinical stage at ART initiation  
     I 
     II 
     III 
     IV 
 
208 (75.6%) 
17 (68.0%) 
8 (53.3%) 
1 (100.0%) 
 0.209 
Previous OIs  
     No  
     Yes 
 
208 (75.6%) 
26 (63.4%) 
 0.096 
Weight at ART initiation 
     < 55 kg 
     > 55 kg 
 
27 (69.2%) 
207 (74.7%) 
 0.463 
EGA at ART initiation 
     1
st
 Trimester 
     2
nd
 Trimester 
     3
rd
 Trimester 
 
18 (94.7%) 
162 (84.4%) 
54 (51.4%) 
 <0.001* 
BMI at ART initiation 
     Underweight 
     Normal 
     Overweight 
 
1 (100.0%) 
84 (81.6%) 
85 (68.0%) 
 0.104 
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 Number retained in Care (%)  p-value 
     Obese 64 (77.1%) 
Relationship to Rx supporter  
     Husband 
     Boyfriend 
     Mother  
     Sister 
     Other 
 
86 (83.5%) 
14 (66.7%) 
70 (64.8%) 
38 (82.6%) 
26 (68.4%) 
 0.062 
Previous PMTCT  
     Yes 
     No 
 
46 (82.1%) 
22 (66.7%) 
 0.097 
CD4 cell count trend  
     Going up 
     Dropping 
     N/A 
 
201 (93.1%) 
9 (75.0%) 
24 (27.3%) 
 <0.001* 
Baselines (Hb, LFTs or KFTs)  
     Yes 
     No 
 
214 (81.7%) 
16 (43.2%) 
 <0.001* 
Any reported side effects  
     No 
     Yes 
 
210 (73.2%) 
24 (82.8%) 
 0.262 
Changes of Regimen  
     No 
     Yes 
 
204 (72.1%) 
30 (90.9%) 
 0.020* 
Any reported poor adherence  
     No 
     Yes 
 
214 (79.6%) 
20 (42.6%) 
 <0.001* 
Family Planning Use on Last Visit  
     None 
     Oral 
 
106 (83.5%) 
33 (84.6%) 
 <0.001* 
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 Number retained in Care (%)  p-value 
     Injectable 
     IUCD 
     Bilateral tubal ligation 
     N/A 
91 (91.9%) 
1 (100.0%) 
2 (100.0%) 
1 (2.1%) 
Weight on the last ART refill visit 
     < 55 kg 
     > 55 kg 
 
55 (79.7%) 
179 (74.0%) 
 0.330 
Weight changes on ART 
     Weight gain 
     Weight loss 
     No change 
 
62 (77.5%) 
152 (82.6%) 
20 (42.6%) 
 <0.001* 
BMI on the last ART refill visit 
     Underweight 
     Normal 
     Overweight 
     Obese 
 
7 (87.5%) 
97 (82.2%) 
76 (67.3%) 
54 (79.4%) 
 0.040* 
Consistent Condom Use at ART 
initiation 
     Yes 
     No 
 
159 (76.8%) 
75 (68.8%) 
 0.123 
Partner Status Known at initiation 
     Positive 
     Unknown 
 
82 (82.0%) 
148 (70.5%) 
 0.088 
Disclosure to the partner at initiation 
     Yes  
     No 
 
133 (78.2%) 
101 (70.1%) 
 0.015* 
Partner on ART  
     Yes 
     No 
 
39 (86.7%) 
44 (80.0%) 
 0.002* 
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 Number retained in Care (%)  p-value 
     N/A 151 (70.9%) 
History of alcohol  
     Yes 
     No 
 
6 (60.0%) 
228 (75.7%) 
 <0.001* 
History of smoking  
     Yes 
     No 
 
0 (0.0%) 
234 (75.7%) 
 <0.001* 
Financial challenges at ART initiation 
     Yes 
     No 
 
34 (70.8%) 
200 (75.5%) 
 0.011* 
* Significant at 5%* 
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Patient-related Factors 
Age was significantly associated with probability of being retained in care at ART initiation 
(p=0.014). LTFU was highest among younger women aged 15 – 24 years at 36.7%; and 
decreasing with increase in age, with those between 25 – 34 years and 35 – 44 years reporting 
LTFU at 21% and 15% and no LTFU among women above 45 years (Table 4.4).  
Level of education was not significantly associated with the chance of being retained in care at 
ART initiation (p=0.389). Retention in care was lowest in the women who had no education at 
ART initiation at 57.1% and increased with increasing level of education, with those who had 
attained primary, secondary and tertiary education being retained in care at 76.5%, 71.6%, 73% 
and 85.7% respectively. 
The estimated gestational age at ART initiation was significantly associated with retention on 
ART (p<0.001). The majority, 94.7% of the women initiated during the first trimester were 
retained in care compared to 84.4% and 51.4% of the women retained in care after being initiated 
on ART during the second and third trimester respectively. 
Retention on ART was not significantly associated with weight of the women at ART initiation 
(p=0.463) and on the last ART visit (p=0.330). However, weight changes after initiation of ART 
were significantly associated with retention in ART care (p<0.001). The majority, 82.6% of 
women losing weight after ART initiation were retained in care compared to 77.5% and 42.6% 
of those gaining weight and with no changes in weight being retained in care respectively.  
BMI at ART initiation was not significantly associated with retention in care (p=0.104). 
Underweight pregnant women were less likely to become LTFU than women in other weight 
categories in which at least a 19% of the patients were LTFU. However, BMI on last ART visit 
had a significant association with retention in care (p=0.040). Women who were overweight on 
the last ART visit were the least likely (67.3%) to be retained in care than other underweight, 
normal and obese BMI categories whose retention rates were at 87.5%, 82.2% and 79.4% 
respectively. 
Pregnant women acknowledging consistent condom use at ART initiation were retained in ART 
care better than those reporting inconsistence at retention rates 76.8% and 68.8% respectively. 
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However, the association between retention in care and reported consistent condom use at ART 
initiation was not statistically significant (p=0.123). 
Disease related factors 
There was no significant association between the duration between testing HIV positive and 
ART initiation (p=0.444). It took on average 35 (SD=10.13) days for a women to be initiated on 
ART from the time of testing HIV positive. Interestingly, women who took more than 3 months 
to be initiated on ART had a comparable retention on ART with to those who took less than 3 
months to be initiated on ART. In addition, presence of comorbidities did not show any 
statistical significance (p=0.504). Those women with no other co-morbidities such as asthma, 
diabetes among others were more likely to be retained in ART care than to those having co-
morbidities at 74.4% and 66.7% respectively.  
The WHO clinical staging at ART initiation was not significantly associated with retention in 
care (p=0.209). All women initiated on ART in HIV Stage 4 were retained in care. At least three 
quarters, two thirds and half of the women initiated on ART in Stages 1, 2 and 3 respectively 
were retained in care. Furthermore, presence of previous opportunistic infections also had no 
significant association with retention in care (p=0.096).  
Having a previous exposure to ARVs for PMTCT was not significantly associated with retention 
in care (p=0.097). The majority, 82.1% of the pregnant women initiated on ART having a 
previous exposure to a short course of ARVs for PMTCT were retained in care better compared 
to 66.7% of those who were taking a PMTCT regimen for the first time.  
 
Socio-economic Factors 
There is a significant association between marital status of the woman at ART initiation with 
retention in care (p=0.006). Patients who were married were more likely to be retained in care 
than pregnant single women. About 82.6% of the married women initiated on ART during 
pregnancy were retained in care compared to 68.7% single women initiated on ART, retained in 
care.  
Relationship to the treatment supporter was not significantly associated with retention at ART 
initiation (p=0.062). LTFU was lowest among those having their husbands as treatment 
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supporters at 16.5% followed by those whose treatment partners were their sisters. Those 
pregnant women who had their mothers as treatment supporters had the highest probability of 
becoming LTFU at 35.2%. 
Employment status was not significantly associated with retention in care at ART initiation 
(p=0.096). However, those employed had a higher probability of being retained in care than 
those who were unemployed at ART initiation at 78.3% and 71.5% respectively. 
There was a statistically significant association between disclosing one’s HIV status to the 
partner and retention in care (p=0.015). Disclosure of HIV status to the partner before ART 
initiation helped women to be retained in care. Non-disclosure to the partner before ART 
initiation continues to be a critical barrier to retention at King Sobhuza II PHU. Stigma remains a 
very serious impediment to long-term retention as those women who did not disclose were more 
likely to become lost to follow up. However, the association between knowing the partner’s 
status and retention care was not significant (p=0.088). At ART initiation, 82% of pregnant 
women who knew their partners to have a positive status were retained in care. Only 70.5% and 
66.7% of the women who did not know the status of their partners and those with undocumented 
status respectively were retained in care.  
The association between retention in ART care and having partners on ART by the time women 
are initiated on ART achieved statistical significance (p=0.002).Pregnant women whose partners 
were on ART were retained in ART care better than those whose partners were not on ART at 
retention rates of 86.7% and 80% respectively.  
History of alcohol consumption at ART initiation was significantly associated with the 
probability of being retained in care (p<0.001). In addition, history of smoking at ART initiation 
was significantly associated with the probability of being retained in care (p<0.001). Those who 
neither consumed alcohol nor smoked were retained in care better than those who consumed 
alcohol or smoked.  
Acknowledging having no financial problems on the ART initiation visit was significantly 
associated with the chance of being retained in care (p=0.011). Those who acknowledged facing 
financial challenges at ART initiation were less likely to be retained in care than those who said 
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they had no financial challenges. 
Treatment Regimen-related Factors 
The choice of the ART regimen at ART initiation was found to be significantly associated with 
retention in care (p=0.002). About 78.5% of pregnant women initiated on the preferred first line 
regimen, Zidovudine, Lamivudine and Nevirapine were retained in care better than those 
initiated on other alternative regimen such as Tenofovir, Lamivudine and Efavirenz and 
Tenofovir, Lamivudine and Nevirapine on which 57.6% and 50% of the women were retained in 
care respectively. In addition, history of poor adherence on the subsequent visit was found to be 
significantly associated with retention on ART (p<0.001). Women who had a history of poor 
adherence to ART were less likely to be retained in care at 42.6% than those never had 
challenges with adherence at 79.6%. However, the association between retention in care and any 
reported side effects was not statistically significant (p=0.262). Retention in care was noted to be 
better in women who experienced side effects than those who never experienced any side effects 
at rates of 82.8% and 73.2% respectively. 
On the last ART visit, the change of ART combination was significantly associated with the 
probability of being retained on ART (p=0.02). Those who had changes in regimen were noted to 
be retained in care better than those who maintained the same regimen. About 90.9% of the 
women initiated on ART during pregnancy who had changes in regimen were retained in ART 
whilst 72.19% who maintained their regimen were retained on ART.  
Starting any contraceptive other than the condom for family planning after delivery was found to 
be statistically associated with retention on ART for pregnant women initiated on ART during 
pregnancy (p<0.001). On the last ART visit, women who started any contraceptive other than the 
condom for family planning after delivery had a better retention on ART than those who never 
started any family planning method other than the condom. Lost to follow up was found to be 
further compounded by those women who could not start any contraceptive for family planning.  
Regular CD4 cell count monitoring was noted to be associated with the probability of being 
retained in care on the last ART visit (p<0.001).Women who had regular CD4 cell count done 
for immunological monitoring whilst on ART had a lower risk of getting lost to follow up. In 
addition, those with CD4 cell count trends going up were retained better than those women with 
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dropping CD4 cell counts, and the association was statistically significant (p<0.001). 
Nevertheless, baseline CD4 cell count had no significant association with retention in care 
(p=0.348).  
Health systems factors 
Having results of at least haemoglobin, liver function tests or kidney function tests at ART 
initiation was significantly associated with retention in care (p<0.001). The highest rate of 
retention in care was observed among women who had documented and interpreted baselines 
results of liver function tests, or kidney function tests haemoglobin levels at 81.7%.  
However, the association between distance to the health facility and retention in care was not 
significant (p=0.448). Women staying further than 16 km had a highest likelihood of being 
retained in care at 83.3% whereas those staying 11 – 15 km from the PHU had the highest risk of 
being LTFU at 30.3%. 
 
4.3 Retention rates from survival curves at different time intervals 
The retention rates on ART at King Sobhuza II PHU were also estimated using the Kaplan-Meier 
survival functions at 6, 12, 24 and 36 months.   
According to the survival curves shown in Figure 4.5, the retention rates at 6, 12, 24 and 36 
months is 83.5%, 79.1%, 76.5%, 73.1% respectively. Women initiated on ART during pregnancy 
had an 83.5% chance of being retained in care at 6 months at King Sobhuza II PHU. At 12, 24 
and 36 months the probability of being retained in care decreased to 79.1%, 76.5% and 73.1% 
respectively. The proportion that was not retained in care was LTFU after factoring out the 
known deaths and transfers out, who were excluded from the study population. 
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Figure 4.5: Retention rates at different time intervals 
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4.4 Predictors of retention in care for women initiated on ART during pregnancy 
 
Bi-variate analysis proved the following to be statistically significant risk factors of poor 
retention in care for women initiated on ART during pregnancy, at ART initiation; age, marital 
status, ART regimen initiated, disclosure to the partner, EGA, interpretation of other laboratory 
investigations, partner on ART, history of smoking and alcohol consumption and reporting 
financial challenges. Significant factors on the last ART refill visit include; BMI, changes in 
regimen, CD4 cell counts trend, any reported poor adherence and family planning use. 
Independent variables that were significantly associated with retention of pregnant women in 
ART care in the bivariate analysis were further analysed by Cox regression to explore the 
relationship between the survival of the women and several explanatory variables. 
4.4.1 Predictors of retention in care at ART initiation 
The following factors were analysed to assess the relationship between variables and survival 
time after ART initiation; age, marital status, estimated gestational age, trimester, history of 
alcohol consumption, history of smoking, reported financial challenges, documented and 
interpreted baseline results, disclosure to the partner, partner known to be on ART and regimen 
initiated. Table 4.5 shows the survival analysis of predictors of retention in care at ART 
initiation. 
The hazard of LTFU was reduced with increasing age. As shown in Table 4.5, there was a 
decrease of 7.5% in the hazard of being LTFU for a one year increase in age, and this achieved 
statistical significance (p=0.001).  
Pregnant women who were single at the time of ART initiation were found to have a 1.999-fold 
increased hazard of becoming LTFU as compared to those who were married (Figure 4.6). This 
implies that at ART initiation, pregnant women who are married had a reduced risk of becoming 
LTFU as compared to single pregnant women. This could probably mean that the former had less 
psychosocial support compared to the latter and hence would not stay long-term ART. The 
difference achieved statistical significance (p=0.006). 
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Key: 1 – Married 2 – Single 
 
 
Figure 4.6: Survival of women according to marital status 
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There was an increase of 10.3% in the hazard of becoming LTFU for every week increase in 
estimated gestational age. Of the women initiated on ART, those who came at lower gestational 
age are more likely to be retained in care than those coming late and this was statistically 
significant (p<0.001). Similarly, pregnant women initiated on ART in the third trimester (HR 
12.387; p=0.013) had an increased risk of becoming LTFU as compared to the first trimester. 
However, the 3.297 increase in hazard of becoming LTFU in the second trimester as compared 
to the first trimester was not statistically significant (p<0.241). 
In this study, pregnant women who did not consume alcohol had a 44.8% reduction in the hazard 
of being LTFU as compared to those who did consume alcohol. However, this reduction was not 
statistically significant (HR 0.552; p=0.248). Consequently, the hazard between those who a 
history of smoking and those with no history of smoking at ART initiation was statistically 
significant (HR 0.171; p=0.792). The hazard of becoming LTFU was reduced by 82.9% in those 
who had a history of smoking at ART initiation compared to those who did not smoke. 
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Table 4.5:  Predictors of retention in care at ART initiation 
 
 Hazard ratio 95% CI p‐value 
     Age 0.925  0.882 – 0.970 0.001* 
     Marital Status    
             Married** 1.000   
             Single 1.999 1.217 – 3.284 0.006* 
     EGA 1.103  1.070 – 1.137 <0.001* 
     Trimester    
             1
st
 Trimester** 1.000         
             2
nd
 Trimester 3.297  0.450 – 24.179         0.241 
             3
rd
 Trimester 12.378 1.710 – 89.616         0.013* 
     History of alcohol 
consumption 
   
             Yes** 1.000   
             No 0.552 0.202 – 1.512 0.248 
     History of smoking    
              Yes** 1.000   
              No 0.171 0.042 – 0.698 0.014* 
     Reported financial challenges    
              Yes** 1.000   
              No 0.808 0. 454 – 1.440 0.470 
     Documented Baseline results    
              Yes** 1.000   
              No 4.600 2.742 – 7.717 <0.001* 
     Disclosure to the partner    
              Yes** 1.000   
              No 1.451 0.935 – 2.252 0.097 
     Partner known to be on ART    
              Yes** 1.000   
              No 1.569  0.580 – 4.242 0.375 
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     Regimen                                              
              AZT+3TC+NVP** 1.000   
              TDF+3TC+EFV 2.569 1.592 – 4.145 <0.001* 
              TDF+3TC+NVP 3.044 0.951 – 9.745 0.061 
 
* Significant at 5%; ** Reference category 
 
Pregnant women who reported no financial challenges at ART initiation had a 19.2% reduction 
in the hazard of becoming LTFU as compared to those women who reported financial problems. 
The difference was statistically non-significant (HR 0.808; p=0.470). In addition, those women 
who had no results of baselines such as haemoglobin levels, kidney function tests or liver 
function tests had a 4.6 fold increase in the hazards of becoming LTFU as compared to those 
who had documented and interpreted  baselines (HR 4.600; p<0.001). 
At ART initiation, pregnant women who had not disclosed their HIV status to their partners were 
found to have a 1.451-fold increased hazard of becoming LTFU as compared to those who had 
disclosed their HIV status to the partners. However, this difference did not achieve statistical 
significance (HR 1.451; p=0.097). Consequently, those who knew that their partners were not on 
ART also had a 1.569-fold increased hazard of becoming LTFU as compared to those who knew 
that their partners were on ART and this did not achieve statistical significance (HR 1.569; 
p=0.375). 
Pregnant women initiated on a twice daily regimen – Tenofovir, Lamivudine and Nevirapine – a 
dual fixed dose combination and a single formulation of Nevirapine, had a 2.569-fold increased 
hazard of becoming LTFU as compared to those on the preferred first line regimen – Zidovudine, 
Lamivudine and Nevirapine – a triple fixed dose combination taken twice daily. The difference 
was statistically significant (HR 2.569; p<0.001). Similarly, those on a once daily regimen – 
Tenofovir, Lamivudine and Efavirenz – a triple fixed dose combination,  had a 3.044-fold 
increased hazard of becoming LTFU as compared to those on the preferred first line regimen but 
without statistical significance (HR 3.044; p=0.061). 
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Table 4.6:  Predictors of retention in care on the last ART clinic visit 
 
Variable Hazard Ratio 95% CI p-value 
     CD4 cell count trend    
              Going up 1.000**   
              Dropping 4.021   1.163 – 13.900             0.028* 
     Changes of ART regimen    
              No 1.000**   
              Yes 0.284  0.090 – 0.901 0.033* 
     History of poor ART adherence    
              No 1.000**   
              Yes 2.871 1.810 – 4.5553 <0.001* 
     Family planning use    
              None 1.000**   
              Oral 0.883 0.356 – 2.188 0.788 
              Injectable 0.459 0.203 – 1.037 0.061 
              IUCD 0.000 0.000 – 0.000 0.982 
              Bilateral tubal ligation 0.000 0.000 – 0.000 0.973 
     Weight changes on ART    
               No change 1.000**   
               Weight loss 0.268 0.148 – 0.488 <0.001* 
               Weight gain  0.200 0.119 – 0.334 <0.001* 
     Body Mass Index    
               Underweight 1.000**   
               Normal 0.563 0.074 – 4.278 0.578 
               Overweight 0.850 0.432 – 1.671 0.637 
               Obese 1.745 0.943 – 3.229 0.076 
 
* Significant at 5%; ** Reference category 
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4.4.2 Predictors of retention in care on the last ART visit 
The following factors were analysed to assess the relationship between variables and survival 
time at on the last ART refill visit; CD4 cell count trend, changes of ART regimen, history of 
poor ART adherence, family planning use, weight changes on ART and BMI. Table 4.6 shows 
the survival analysis of predictors of retention in care on the last ART clinic visit.  
Women who had dropping CD4 cell count trends on the last ART clinic visit were found to have 
a 4.021-fold increased hazard of becoming LTFU as compared to those who had CD4 cell counts 
going up. This implies that on the last ART refill visit, women who had CD4 cell count going up 
had a reduced risk of becoming LTFU as compared to those with dropping CD4 cell counts. The 
difference achieved statistical significance (HR 4.021; p=0.028).  
The hazard of becoming LTFU was reduced by 71.6% among women who had changes in their 
regimen as compared to those who never had changes in their ART regimen (Figure 4.7). This 
means that those who don’t have changes in their ART regimen stand a higher risk of LTFU as 
compared to those having changes in their regimen. The difference achieved statistical 
significance (HR 0.284; p=0.399). This could be due to lack of counselling provided to women 
who never have changes in their ART regimen as compared to the counselling provided to those 
having or about to have changes in their regimen. 
Women who had a history of poor adherence on the last ART refill visit were found to have a 
2.871-fold increased hazard of becoming LTFU as compared to those who never had poor 
adherence before. On the last ART refill visit, women who had no history of poor adherence had 
a reduced risk of becoming LTFU as compared to those with a history of poor adherence, and 
this achieved statistical significance (HR 2.871; p<0.001).  
Women who started family planning use after delivery had a reduced hazard of becoming LTFU 
as compared to those who never used any family planning method such as oral contraceptives 
(HR 0.883; p=0.788), injectable (HR 0.459; p=0.061), intrauterine contraceptive device (HR 
0.000; p=0.982) and bilateral tubal ligation (HR 0.000; p=0.973). However, these differences 
were not statistically significant. 
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Figure 4.7: Survival of women according to changes of regimen  
 
The hazard of becoming LTFU was reduced by 73.2% in women who had weight loss from ART 
initiation to the last ART refill visit as compared to those who had no chance from the pregnancy 
weight at ART initiation to the last ART refill visit. This difference was statistically significant 
(HR 0.268; p<0.001). Similarly, those with weight gain had an 80% reduction in the hazard of 
being LTFU as compared to those who had no chance from the pregnancy weight at ART 
initiation to the last ART refill visit (HR 0.200; p<0.001). 
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Patients who had normal BMI were found to have a 43.7% reduction in hazard of becoming 
LTFU relative to those underweight. Nevertheless, the difference did not achieve statistical 
significance (HR 0.563; p=0.578). Similarly, the hazard of becoming LTFU was reduced by 15% 
in women who were overweight as compared to those underweight (HR 0.850; p=0.637). 
Consequently, women who were overweight on the last ART refill visit were found to have a 
1.745-fold increase in the hazard of becoming LTFU as compared to those who were 
underweight (HR 1.745; p=0.076). 
 
4.5 Summary 
Bi-variate analysis found the following to be statistically significant risk factors of poor retention 
in care for women initiated on ART during pregnancy, at ART initiation; age, marital status, 
ART regimen initiated, disclosure to the partner, EGA, interpretation of other laboratory 
investigations, partner on ART, history of smoking and alcohol consumption and reporting 
financial challenges. Significant factors on the last ART refill visit include; BMI, changes in 
regimen, CD4 cell counts trend, any reported poor adherence and family planning use.  
After further analysis using Cox regression, statistically significant factors of poor retention in 
care at ART initiation include; younger women; single pregnant women, higher EGA, being 
initiated in third trimester, history of smoking, no other baseline results and being initiated on an 
ART regimen that is not the preferred regimen. In addition, the significant risk factors of poor 
retention in care on the last ART refill visit included; dropping CD4 count trend, no changes to 
the ART regimen, history of poor ART adherence and weight gain or loss. 
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5 DISCUSSION 
This study is one of the first to investigate the factors contributing to poor retention among 
women who initiate ART during pregnancy in Swaziland. The significant risk factors 
investigated are supposed to reflect the risk factors for poor retention among women who initiate 
ART during pregnancy for a given environment. These findings are particularly important for the 
national PMTCT programmes to prioritise the identification of patients with a high likelihood of 
being LTFU for intensified patient education and counselling to foster sustained viral load 
suppression and patient retention in care.  
 
5.1 Retention in care 
Retention rates for women initiated on ART during pregnancy at King Sobhuza II PHU at 6, 12, 
24 and 36 months were 83.5%, 79.1%, 76.5%, 73.1% respectively. These rates are much lower 
than those elicited in a study done for all ART patients in Zimbabwe (Mutasa-Apollo et al., 
2014) and those estimated by Fox and Rosen (2010) in a meta-analysis of published cohort data 
from 16 countries in sub-Saharan Africa. In the meta-analysis, the estimated retention rates of 
ART patients at 6, 12, 24 and 36 months were 86.1%, 80.2%, 70.0% and 64.6% respectively. 
Also, in the Zimbabwe Study the rates of patient retention at 6, 12, 24 and 36 months were 
90.7%, 78.1%, 68.8% and 64.4%, respectively. The retention rate for women initiated on ART 
during pregnancy at 6 months is lower than in the general adult population on ART. In addition, 
the study identified that 47.6% of the women becoming LTFU are lost in ART care before 
delivery compared to 52.4% who are lost after delivery. Given that the median EGA at ART 
initiation was 24 weeks (IQR: 18 – 31), most women became LTFU by 6 months of ART 
initiation. 
 
5.2 Factors associated with retention in care 
The observed association of poor retention in care of the women initiated on ART during 
pregnancy with some patient related factors, socio-economic factors, disease related factors, 
treatment regimen related factors and health system related factors are consistent with other 
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knowledge (WHO, 2009). The statistically significant patient related factors included age, 
estimated gestational age at ART initiation, BMI on the last ART visit and trend of CD4 cell 
count done for monitoring purposes. Effected changes in the ART regimen, any reported side 
effects, family planning use after delivery, any prior poor adherence to ART and the actual 
regimen initiated were identified as the significant drug related factors. The socio-economic 
factors which were associated with retention in care were as follows: marital status, disclosure to 
partner at ART initiation, whether the partner is also on ART, history of smoking and alcohol 
consumption at ART initiation and acknowledgement of financial challenges at ART initiation. 
Health system related factors included the distance to the facility and documentation and 
interpretation of the other baseline investigations.  
5.2.1 Age 
Age at ART initiation was identified as a contributing factor to retention in care with older 
women retained better in care than the younger women. Similarly, Hodgson et al. (2014) also 
identified lower ages as a barrier to retention in ART care and higher ages as an enablers to 
retention in care. Of the women above 45 years, all of them were retained in care compared to 
85%, 79% and 63.3% for the age groups 35 – 44, 25 – 34 and 15 – 24 years respectively.  
5.2.2 Baseline CD4 cell count and regular CD4 cell count monitoring 
For women who were initiated on ART during pregnancy, the mean observed CD4 cell count 
was 250 cells per ml at baseline. The trend of CD4 cell counts done for monitoring purposes for 
women already on ART showed that only 3.8% of the women had dropping CD4 cell count 
during the duration of the study. These findings are consistent with findings from other studies in 
Africa demonstrating good immunologic response to ART (Coetzee et al., 2004). Contrary to the 
findings by Mutasa-Apollo et al. (2014), baseline CD4 cell count was found not to be 
significantly associated with retention in care. This finding is similar to what was elicited by 
Toro et al. (2010) that poor programme retention was not associated with CD4 cell count. 
5.2.3 Estimated gestational age (EGA) at ART initiation 
Nationally, pregnant women are having their first booking at 18 weeks (Swaziland Ministry of 
Health, 2014) and based on the study findings, the EGA at ART initiation was 24 weeks. In 
addition, 97% of the pregnant women nationally are tested on the first antenatal care (ANC) 
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visit. This means that on average it took 6 weeks for the women to initiate ART and is further 
supported by the duration between testing and ART initiation which was on average 35 
(SD=10.13) days. EGA at ART initiation was found to be significantly associated with retention 
in care. Women who were initiated on ART in the third trimester were less likely to be retained 
in care compared to those initiated in the first trimester.. 
5.2.4 BMI on the last ART refill visit 
The study elicited low BMI as an enabler of retention and high BMI as a barrier to ART 
retention. Contrary to this finding, Thida et al. (2014) alluded to low BMI contributing to poor 
retention in ART care.  This could be due to the popular belief in Swaziland that being 
overweight or obese is a sign of good living resulting in poor retention in ART care. Those with 
low BMI receive other services such as food by prescription thereby further encouraging them to 
be retained in care.  
5.2.5 Regimen   
The recommended first line regimen for pregnant women in Swaziland according to the 2010 
WHO PMTCT Guidelines Option A was Zidovudine, Lamivudine and Nevirapine. Consistent 
with the recommendation, 79.4% of the women initiated on ART were initiated on this regimen. 
This regimen was significantly associated with retention in care. Similarly, Harries, Zachariah, 
Lawn and Rosen (2010) highlight consideration of simple, non-toxic ART regimens as key 
interventions to improve retention in care. This could be further strengthened by availability of 
the regimen as a fixed drug combination, which is taken once a day. The other available 
regimens come as dual fixed dose combinations and separate third drug are taken at least twice a 
day.   
Women who had their regimen changed for severe side effects or adverse drug reactions were 
retained well in care because they received additional counselling on the new regimen. This 
could also probably mean that those whose ART combination was not changed lost hope and 
stopped treatment, perhaps thinking they were on an inferior combination Also, prior ART 
adherence challenges had a statistically significant association with poor retention. Most of the 
patients who ended up being LTFU had previous episodes of poor adherence. As for the general 
patients on ART, Makunde et al. (2012) highlighted that adherence to ART is an important 
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aspect for ART programmes to attain retention of patients in ART care. Similarly, the study 
identified prior adherence challenges as a contributing factor to poor retention in care. The 
majority, 79.6% of the women with no reported poor adherence were retained in care compared 
to only 42.6% of those women who reported prior adherence challenges. This could be due to the 
same factors contributing to both poor adherence and poor retention in care.  
5.2.6 Distance to the health facility 
Despite the findings from Mozambique showing that long distance travel to healthcare facilities 
reduce retention on ART (WHO, 2011), distance was found to be non-significant. This could be 
due to the short distances in Swaziland where only 11.4% of the women were staying more than 
16km away from the health facility. However, those women who acknowledged financial 
challenges at ART initiation had a lower retention than those who had no financial challenges. 
This association was also statistically significant. 
5.2.7 History of smoking and alcohol consumption at ART initiation 
Individuals with alcohol and other substance use disorders including cigarette smoking are at 
increased risk of poor retention in care, poor adherence, and virological failure (Leisegang et al., 
2011; Krishnan et al., 2011). Similarly, pregnant women initiated on ART during pregnancy and 
have a history of either smoking or alcohol consumption were noted to have poor retention.  
5.2.8 Documentation and interpretation of the other baseline investigations 
Interpretation of documented baseline results such as haemoglobin, liver function and kidney 
function tests was identified as a determinant of retention in care for pregnant women initiated 
on ART during pregnancy. Explaining the results to the women could allay all the anxieties 
about the side effects of ARVs and make the women more confident to persist in care. 
5.2.9 Disclosure to partner at ART initiation 
Non-disclosure to the partner before ART initiation continues to be a critical barrier to retention 
at King Sobhuza II PHU. Stigma remains a very serious impediment to long-term retention as 
those women who did not disclose were more likely to become lost to follow up than those 
disclosing to their partners. As elicited by the study, disclosure of HIV status by pregnant women 
 
 
 
 
59 
 
to the partners at ART initiation was significantly associated with retention in ART care. 
Similarly, studies have shown that disclosure has added public health benefits that include 
improved uptake of PMTCT services, increased ART use (Waddell & Messeri, 2006) and 
retention in care (Halperin 2013). The disclosure rates among pregnant women initiated on ART 
at King Sobhuza II PHU were very low as only 58.3% of the women had disclosed their HIV 
status by the time of ART initiation. There is need to foster disclosure to partners through 
counselling and patient education to empower the women to make informed choices that can lead 
to risk behaviour reduction. 
5.2.10 Family planning use after delivery 
According to Harries, Zachariah, Lawn and Rosen (2010), the ART programme can be used as 
an opportunity to improve holistic linkages and provide additional services such as nutritional 
assessment, counselling and support, and family planning, which in return may encourage better 
retention in care. The study showed that using family planning had better retention than those not 
using any family planning. In addition, use of family planning was elucidated as significant 
factor for retention in care. This then means that family planning counselling should be the 
mainstay of counselling during the antenatal visits so that they start family planning methods as 
soon as possible after delivery. 
5.2.11 Marital status 
The study identified the association between marital status and retention in care. In addition, 
having the partner who is on ART improved retention in women initiated on ART during 
pregnancy. This could be due to the psychosocial support from the male partner after ART 
initiation. According to Hodgson et al. (2014), one study found lack of male involvement as a 
barrier to ART retention and another found it as an enabler.   
 
5.3 Limitations of the study 
The study had several limitations. These limitations were mainly related to documentation in the 
medical records by the facility staff. The PHU ART register had a lot of missing data. However, 
triangulation of data sources such as the patient’s chronic care file and the electronic database 
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was used. All missing data on the independent variables were documented but not imputed. 
There was likelihood that the data sets with missing variables could introduce a hidden bias 
which had a positive or negative effect on the outcomes of interest. To minimise this bias, 
missing values for both numeric and character variables were explicitly labelled as missing in 
tables and data listings.  
The above mentioned limitations may therefore lead to biased estimates on retention of pregnant 
women initiated on ART during pregnancy and factors associated with poor retention in care in 
the PHU cohort. 
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6 CONCLUSION AND RECOMMENDATIONS 
6.1 Conclusions 
This study is one of the first of its kind conducted in Swaziland and the findings have provided 
useful baseline data on the retention rates and some insights into the determinants of retention in 
care among women initiated on ART during pregnancy at King Sobhuza II PHU. However, 
further studies are required at National level to support this study. 
Poor retention in care can result in negative HIV clinical outcomes such as reduced ART 
survival rates, increased incidence of opportunistic infections, increased HIV transmission and 
high possibilities of developing drug resistance. Thus, in view of the individual and public health 
implications of poor retention in care, these findings indicate an urgent need to improve and 
sustain high rates of retention in care among women initiated on ART during pregnancy at King 
Sobhuza II PHU. This may in part be achieved by provision of intensive education and 
counselling, use of support groups or treatment clubs (Bedelu et al., 2007), strengthening of 
defaulter tracking systems (Mwatawala et al., 2012; Chalker et al., 2013) and availing retention 
data as part of routine data in PMTCT and ART programmes. In addition, the findings from this 
study show that there is need for efforts are to ensure that PLHIV seek ART before their HIV 
infection progresses to advanced stages. 
The study elicited retention rates for women initiated on ART during pregnancy at King Sobhuza 
II PHU of 83.5%, 79.1%, 76.5%, 73.1% of 6, 12, 24 and 36 months respectively, which are 
lower than those of the general adult population on ART. According to the Swaziland Ministry 
of Health (2014), the 6 months retention in care for adults on ART remains high at 96% and the 
12, 24 and 36 months retention rates drop to 88%, 82% and 78% respectively. The higher rates 
retention in care reported in the general population on ART or similar clinical studies in other 
sub- Saharan African settings point to the feasibility of achieving higher rates of retention in care 
among women initiated on ART during pregnancy in this setting. 
Similarly, in light of the scaling up the ART programme in Swaziland, there is need to not just 
monitor the rates of retention in among women initiated on ART during pregnancy, but also to 
identify and address factors contributing to poor retention in care. Addressing the identified 
factors ensures that the increasing number of patients receiving ART would realise the fully 
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intended benefits of ART. The study found that the significant risk factors of poor retention in 
care for women initiated on ART during pregnancy, at ART initiation; age, marital status, ART 
regimen initiated, disclosure to the partner, EGA, interpretation of other laboratory 
investigations, partner on ART, history of smoking and alcohol consumption and reporting 
financial challenges. This means that for any pregnant woman initiating ART the significant 
factors listed above should indicate the risk of being poorly retained in care. The significant 
factors on the last ART refill visit include; BMI, changes in regimen, CD4 cell counts trend, any 
reported poor adherence and family planning use. These factors should also be considered as 
indicators of poor retention in care whenever the women come for their ART refills. 
 
6.2 Recommendations 
Recommendations are provided on monitoring of retention in care and interventions to improve 
retention in care for women initiating ART during pregnancy. In addition, the recommendations 
cover specific issues pertaining to pregnant women although they can be applicable to the 
general population. In accordance to the findings from this study, the following 
recommendations should be considered when there is need to improve retention in care among 
women initiated on ART during pregnancy at King Sobhuza II PHU.  
 Since use of family planning other than just a condom had a significant association with 
retention in care, family planning counselling should be provided during pregnancy, in 
maternity and throughout the breastfeeding period. Furthermore, initiation of 
contraceptive method with ongoing counselling should be done as soon as recommended. 
This calls for integration of family planning services in all units initiating ART in 
pregnant women. 
 Women maintaining their ART regimens should receive ongoing structured adherence 
counselling as they come for their ART refills. Most programmes providing ART provide 
more counselling to those patients changing regimen. In addition to this group of patients, 
counselling should be provided even to those patients maintaining their ART regimens. 
 The study showed that women with dropping CD4 cell counts were less likely to be 
retained in care. Therefore, in any PMTCT or ART programme, women with dropping 
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CD4 cell count and /or unsuppressed viral load should undergo stepped up adherence to 
improve their retention in care. 
 There is need to conduct pill count and calculate adherence percentage in all patients on 
ART when they come for their ART refills. Those with adherence rates less than 95% 
should receive remedial counselling for them to maintain optimal adherence and hence be 
retained in care. 
 Disclosure of HIV status to the partner at ART initiation should be encouraged to all 
pregnant women. Disclosure should be a critical component of post-test and ongoing 
adherence counselling. In addition, women should be equipped with disclosure skills so 
that they can easily disclose to their spouses. Awareness programmes should be 
implemented in male dominated environments to discourage and criminalise domestic 
violence.  
 Since pregnant women with HIV positive partners on ART were retained in care better 
than those whose partners were HIV positive and not on ART, there is need for 
intervention to ensure partner testing and initiation of HIV positive partners. Initiatives 
that prioritise partner testing, couple testing and family testing should be implemented in 
health facilities. 
 Intensive health education and counselling should continue to be provided to women to 
avoid alcohol consumption and smoking. Centres for alcohol, smoking and drug abuse 
rehabilitation should available and accessible with proper referrals and linkages for 
patients with such problems. 
 Efforts should be directed to improve the livelihoods of those acknowledging financial 
challenges at ART initiation. The Ministry of Social Welfare should be engaged to avail 
help to such patients so that they can also be retained in care.  
 Community mobilisation activities should include messages to encourage women to book 
their pregnancies early preferably in the first trimester, family planning use after delivery 
and couple testing during pregnancy. The messages should also be available on 
Information, Education and Communication (IEC) materials, which include brochures, 
pamphlets and billboards among others. The mobilisation may also involve the media, 
newspapers and even the social networks. 
 Health care workers especially nurses initiating patients on ART should be trained on 
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results interpretation since those with documented and interpreted baseline results were 
more likely to be retained in care. 
Retention in care has become an increasing public health problem in low and middle-income 
countries especially in women initiated on ART during pregnancy. This necessitates the 
implementation of appropriate public health interventions: provision of intensive education and 
counselling; use of support groups and treatment clubs; strengthening of defaulter tracking 
systems and availing retention data as part of routine data in PMTCT and ART programmes. 
6.2.1 Strengthening patient tracking systems 
To foster retention in care, reliable patient tracking and tracing systems are prerequisites to the 
identification of patients who have missed visits or are LTFU. This could involve simply putting 
aside the charts of patients who miss appointments, followed by tracing the patient’s 
whereabouts and facilitating their return to care. Besides tracking patients telephonically, efforts 
should be made to conduct home visit through the community health workers. 
6.2.2 Intensive counselling and patient education 
All patients initiated on ART should receive preART counselling and ongoing adherence 
counselling. Adherence counselling during ART can be routine adherence assessments during 
ARV therapy and counselling interventions for patients with poor adherence. Information, 
education and communication (IEC) materials can be used to help women understand the 
counselling messages. These should be available in the health facilities and should be given to 
the patients at all visits. 
6.2.3 Referral for support groups 
Generally, support groups provided peer support for disclosure and members learn from each 
other’s experience. Support groups have been shown to be effective in fostering retention in care 
in some countries (Bedelu et al., 2007). These support groups could be based on sex, age groups, 
HIV status or pregnancy status.  
6.2.4 Use of treatment clubs 
Use of treatment clubs has been shown to improve retention in care. Treatment clubs are groups 
of patients from the same family or geographical area who take turns to visit the ART centre to 
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pick ARVs. These initiatives reduce transport costs and at the same time decongesting health 
facilities whilst promoting retention in care.  
6.2.5 Strengthening of patient tracing systems 
Tracing mechanisms are needed to ensure that all patients initiated on ART are retained in care. 
Different strategies have been implemented in different settings. The process involves 
identification of the patients who have missed appointments, defaulted or become LTFU and 
tracking patients to bring them back to care. The appointment register can be used as part of the 
appointment system to identify patients who have missed appointments, defaulted or become 
LTFU. Different methods can be used to track the identified patients. These include calling 
telephonically, conducting home visits and the use of community health workers to locate LTFU 
patients in their communities. 
6.2.6 Further studies in Swaziland 
Further studies, involving both quantitative and qualitative methods, should be conducted to 
further investigate the factors that influence retention in care among women initiated on ART 
during pregnancy in this setting. This will further strengthen retention in care after adoption of 
lifelong ART for pregnant and lactating women (Option B+ of PMTCT) in Swaziland. 
6.2.7 Availing retention in care indicators as routine data 
At programme level, there is need to have routine data on retention in care. This helps 
programmes to monitor different cohorts and identify patients who miss or default appointments 
and bring them back to care before they are LTFU. 
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APPENDICES  
Appendix 1: Data abstraction tool 
There are three different components used in the data abstraction for this study. The first 
component is about the patient’s demographic and socioeconomic information.  The second 
component is on baseline clinical information. The third component is about clinical information 
at last ART refill visit and the outcomes in relation to retention in care 
# _____        Patient ID: ___________ 
No Question Response 
Demographic and socio-economic status 
1.  Age of patient? Years: ______ 
2.  Residence ____________ 
3.  Distance from KS II  _____ km 
4.  What is the patient’s highest level 
of education? 
 
(Select one) 
None  (1) 
Primary   (2) 
Secondary     (3) 
High school  (4) 
Tertiary  (5)  
5.  What is her current marital status? 
(Select one) 
Married                                    (1) 
Single                                       (2)                         
6.  Employment Status Employed                (1) 
Unemployed                          (2)                          
7.  Parity  ____________ 
8.  Gravida ____________ 
9.  LNMP       ____________ 
10.  EGA ____________ 
11.  Rx supporter    Yes                 (1) 
No                                            (2)                          
12.  Relation to Rx supporter Husband                          (1) 
Boyfriend                          (2) 
Mother                                     (3) 
Sister                                        (4) 
Aunt                                      (5) 
Daughter                                  (6)  
Father                                       (7)  
Other                                        (8) 
13.  Disclosure to the partner at 
initiation? 
Yes                 (1) 
No                                            (2)   
Missing                                    (3) 
14.  Partner status? Positive                          (1) 
Unknown                          (2) 
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No Question Response 
Missing                (3)                          
15.  Is the partner currently on ART? Yes                 (1) 
No                                            (2)   
N/A                                          (3) 
Missing                                    (4) 
16.  History of alcohol  Yes                 (1) 
No                                    (2)   
Missing                                    (3) 
17.  History of smoking Yes                 (1) 
No                                            (2)   
 Missing                                   (3) 
18.  Consent to a home visit by RHMs Yes                 (1) 
No                                    (2)                          
19.  Financial challenges at initiation Yes                 (1) 
No                                    (2)                          
Baseline Clinical Information 
20.  Date of testing Positive     
21.  Weight  
22.  Height  
23.  Consistent Condom Use  Yes                 (1) 
No                                    (2)                          
24.  CD4 cell count  
25.  Documented and interpreted 
baselines (Hb, LFTs or KFTs) 
Yes                 (1) 
No                                    (2)                          
26.  Clinical stage at initiation I                                                (1) 
II                                               (2) 
III                                             (3) 
IV                                             (4) 
27.  Other co-morbidities  None                  (1) 
Yes                                  (2)   
28.  Previous PMTCT Yes                 (1) 
No                                    (2)   
N/A                                          (3) 
29.  ART Start Date  
30.  Regimen AZT+3TC+NVP                                      (1) 
TDF+3TC+EFV                                      (2) 
TDF+3TC+NVP                                             (3) 
Clinical Information while on ART 
31.  Number of CD4 cell counts done  
32.  Most recent CD4 cell count  
33.  Date done  
34.  CD4 cell count trend Going up                                      (1) 
Dropping                                      (2) 
N/a                                                         (3) 
35.  Any reported SEs Yes                 (1) 
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No Question Response 
No                                    (2)                          
36.  Changes of Regimen No                (1) 
Yes                                    (2)                          
37.  Any reported poor adherence No                (1) 
Yes                                   (2)                          
38.  Problem  
Clinical Information at Last ART Refill Visit 
39.  Last Appointment Date  
40.  Weight  
41.  Nutritional Status  
42.  FP Use other than condom use None                                        (1) 
  Oral                                          (2) 
  Injectable                                 (3) 
  IUCD                                       (4) 
  Bilateral tubal ligation             (5) 
  N/A                                          (6) 
43.  Duration of last Refill   
Outcomes 
44.  Date of delivery  
45.  Retained in Care Yes                 (1) 
No                                    (2)                          
46.  If LTFU, timing in relation to 
date of delivery  
Before                                       (1) 
After                                         (2) 
 
 
 
 
 
 
 
